>pdb|8DUE|M Chain M, Open state of T4 bacteriophage gp41 hexamer bound with single strand DNA
NTTTTTTTTT
>OO464939.1 Sequence 258 from patent US 11421011
CCCCGGCGCC
>OO291017.1 Sequence 12 from patent US 11365418
TCTCCTTCTT
>OO289195.1 Sequence 5 from patent US 11365413
AAAAAAAAAA
>OO287246.1 Sequence 105 from patent US 11365226
GCCRCCATGG
>OO097481.1 Sequence 19 from patent US 11312995
ACGTTGGATG
>OO095389.1 Sequence 225 from patent US 11312965
NNNNCGNNNN
>OO095388.1 Sequence 224 from patent US 11312965
NNNCGNNNCG
>OO095387.1 Sequence 223 from patent US 11312965
CGNNNNCGCG
>OO095385.1 Sequence 221 from patent US 11312965
NNNCGCGNNN
>OO095384.1 Sequence 220 from patent US 11312965
NNCGCGNNCG
>OO095380.1 Sequence 216 from patent US 11312965
NNCGNNCGNN
>OO477485.1 Sequence 1183 from patent US 11427837
GACATCGATG
>OO474290.1 Sequence 16 from patent US 11427819
AGCTAGATCC
>OO474289.1 Sequence 15 from patent US 11427819
AGTTAGATCC
>OO471414.1 Sequence 22 from patent US 11421285
TCTACGTAGC
>OO471413.1 Sequence 21 from patent US 11421285
CGTCTAGTAC
>OO471412.1 Sequence 20 from patent US 11421285
TCACGTACTA
>OO471411.1 Sequence 19 from patent US 11421285
ATACGACGTA
>OO471410.1 Sequence 18 from patent US 11421285
CGAGAGATAC
>OO471409.1 Sequence 17 from patent US 11421285
CATAGTAGTG
>OO471408.1 Sequence 16 from patent US 11421285
TACTGAGCTA
>OO471407.1 Sequence 15 from patent US 11421285
TGATACGTCT
>OO471406.1 Sequence 14 from patent US 11421285
TCTCTATGCG
>OO471405.1 Sequence 13 from patent US 11421285
TAGTATCAGC
>OO471404.1 Sequence 12 from patent US 11421285
CTCGCGTGTC
>OO471403.1 Sequence 11 from patent US 11421285
CGTGTCTCTA
>OO471402.1 Sequence 10 from patent US 11421285
ATATCGCGAG
>OO471401.1 Sequence 9 from patent US 11421285
ATCAGACACG
>OO471400.1 Sequence 8 from patent US 11421285
AGCACTGTAG
>OO471399.1 Sequence 7 from patent US 11421285
AGACGCACTC
>OO471398.1 Sequence 6 from patent US 11421285
ACGCTCGACA
>OO471397.1 Sequence 5 from patent US 11421285
ACGAGTGCGT
>OO470909.1 Sequence 9 from patent US 11421275
TTGGGTTTAC
>OO470528.1 Sequence 50 from patent US 11421265
TTAAGAGAAG
>OO470058.1 Sequence 56 from patent US 11421251
GAAACACCGC
>OO469211.1 Sequence 1324 from patent US 11421250
CCGCCTGACG
>OO469207.1 Sequence 1320 from patent US 11421250
CCGCCTGACG
>OO469203.1 Sequence 1316 from patent US 11421250
CCGCCTGACG
>OO469200.1 Sequence 1313 from patent US 11421250
CCGCCTGACG
>OO468465.1 Sequence 8 from patent US 11421242
CACAAAGTAG
>OO468464.1 Sequence 7 from patent US 11421242
CACACTCAAA
>OO459213.1 Sequence 1 from patent US 11414784
GATCCCTCGA
>OO459159.1 Sequence 8 from patent US 11414714
TCACTCTGTC
>OO456397.1 Sequence 395 from patent US 11414686
CAGAGACTGT
>OO456395.1 Sequence 393 from patent US 11414686
GTGTGACTGT
>OO456393.1 Sequence 391 from patent US 11414686
CTCTCTCTGT
>OO455208.1 Sequence 29 from patent US 11414664
TTCCAAGGTT
>OO455207.1 Sequence 28 from patent US 11414664
AACCTTGGAA
>OO443578.1 Sequence 29 from patent US 11408003
TTCCAAGGTT
>OO443577.1 Sequence 28 from patent US 11408003
AACCTTGGAA
>OO420340.1 Sequence 146 from patent US 11407990
GCTTCTCTTC
>OO420339.1 Sequence 145 from patent US 11407990
GAAGAGAAGC
>OO413790.1 Sequence 1350 from patent US 11401532
AAGCCAAAAA
>OO411389.1 Sequence 37 from patent US 11401514
RMAAMVMAAA
>OO411388.1 Sequence 36 from patent US 11401514
RYRVASMNRN
>OO411387.1 Sequence 35 from patent US 11401514
TDTDTDTDTD
>OO411386.1 Sequence 31 from patent US 11401514
BDSYNDVRGB
>OO411385.1 Sequence 30 from patent US 11401514
NNWHHRNNHW
>OO411384.1 Sequence 29 from patent US 11401514
NAYRTATGBV
>OO411383.1 Sequence 28 from patent US 11401514
TABRHATRYD
>OO411382.1 Sequence 27 from patent US 11401514
WWNHNHDNWD
>OO411381.1 Sequence 26 from patent US 11401514
WWNNHNNDWW
>OO411202.1 Sequence 72 from patent US 11401347
GATCCTCGGC
>OO411148.1 Sequence 2448 from patent US 11401346
CTCTTCNNNN
>OO411146.1 Sequence 2446 from patent US 11401346
GACNNNNGTC
>OO411143.1 Sequence 2443 from patent US 11401346
GATNNNNATC
>OO410150.1 Sequence 67 from patent US 11401305
AAGCTTACTC
>OO410149.1 Sequence 66 from patent US 11401305
GAGTAAGCTT
>OO409995.1 Sequence 575 from patent US 11400169
CAYNNNNRTG
>OO409994.1 Sequence 574 from patent US 11400169
CAYNNNNRTG
>OO409993.1 Sequence 573 from patent US 11400169
GAANNNNTTC
>OO409992.1 Sequence 572 from patent US 11400169
CACNNNNGTG
>OO409991.1 Sequence 571 from patent US 11400169
GAANNNNTTC
>OO409990.1 Sequence 570 from patent US 11400169
GATNNNNATC
>OO409989.1 Sequence 569 from patent US 11400169
GAGNNNNNGT
>OO409988.1 Sequence 568 from patent US 11400169
GACNNNNGTC
>OO409987.1 Sequence 567 from patent US 11400169
GATNNNNATC
>OO409986.1 Sequence 566 from patent US 11400169
GATNNNNATC
>OO409985.1 Sequence 565 from patent US 11400169
GATNNNNATC
>OO409984.1 Sequence 564 from patent US 11400169
GATNNNNATC
>OO409983.1 Sequence 563 from patent US 11400169
GACNNNNGTC
>OO409982.1 Sequence 562 from patent US 11400169
GAANNNNTTC
>OO409965.1 Sequence 247 from patent US 11400169
NNNNNGAGAC
>OO409964.1 Sequence 246 from patent US 11400169
GTCTCNNNNN
>OO409938.1 Sequence 123 from patent US 11400169
NNNNGAAGAG
>OO409937.1 Sequence 122 from patent US 11400169
CTCTTCNNNN
>OO409912.1 Sequence 70 from patent US 11400169
NNNNNGACTC
>OO409911.1 Sequence 69 from patent US 11400169
GAGTCNNNNN
>OO409910.1 Sequence 67 from patent US 11400169
NNNNNGACTC
>OO409909.1 Sequence 66 from patent US 11400169
GAGTCNNNNN
>OO409895.1 Sequence 37 from patent US 11400169
NNNNNGAGAC
>OO409894.1 Sequence 36 from patent US 11400169
GTCTCNNNNN
>OO409887.1 Sequence 25 from patent US 11400169
NNNNNGATCC
>OO409886.1 Sequence 24 from patent US 11400169
GGATCNNNNN
>OO408526.1 Sequence 5808 from patent US 11400144
GGGGAAAACT
>OO408490.1 Sequence 5770 from patent US 11400144
ATCAAGACAC
>OO408388.1 Sequence 5664 from patent US 11400144
AGGTGAAAAA
>OO408329.1 Sequence 5603 from patent US 11400144
ATCCTCCTAA
>OO408056.1 Sequence 5316 from patent US 11400144
TCTTACACCT
>OO407916.1 Sequence 5166 from patent US 11400144
GAGTTAAAAT
>OO407851.1 Sequence 5098 from patent US 11400144
AAAAATAACA
>OO407747.1 Sequence 4989 from patent US 11400144
AGGGGATGAA
>OO407617.1 Sequence 4853 from patent US 11400144
ATAATCGCTC
>OO407516.1 Sequence 4749 from patent US 11400144
AAATATTCAC
>OO407374.1 Sequence 4604 from patent US 11400144
ATATATTCCT
>OO406980.1 Sequence 4196 from patent US 11400144
ATTAATCACC
>OO406960.1 Sequence 4176 from patent US 11400144
GTGATTAAAT
>OO406956.1 Sequence 4172 from patent US 11400144
TGGTGATAAT
>OO406949.1 Sequence 4164 from patent US 11400144
AGGGGTTTAA
>OO406880.1 Sequence 4095 from patent US 11400144
TGATTTTATA
>OO406597.1 Sequence 3793 from patent US 11400144
AGGTGTTAAT
>OO406519.1 Sequence 3712 from patent US 11400144
TAGATTTAAA
>OO406512.1 Sequence 3705 from patent US 11400144
TTTAAATCTT
>OO406349.1 Sequence 3533 from patent US 11400144
GGTGATTTTT
>OO406347.1 Sequence 3531 from patent US 11400144
GAGTGATAAC
>OO406306.1 Sequence 3485 from patent US 11400144
GAGAGATTTG
>OO406297.1 Sequence 3475 from patent US 11400144
AGTATGATGT
>OO406170.1 Sequence 3336 from patent US 11400144
GGTGATTTGT
>OO406099.1 Sequence 3263 from patent US 11400144
ACTTATTTTT
>OO406037.1 Sequence 3198 from patent US 11400144
GTTTTTTTAA
>OO406033.1 Sequence 3194 from patent US 11400144
GAATATTTTA
>OO405995.1 Sequence 3153 from patent US 11400144
AGTAAAAAAA
>OO405949.1 Sequence 3107 from patent US 11400144
TAATTTAAAC
>OO402673.1 Sequence 38 from patent US 11400110
GTTTTTGTAC
>OO402665.1 Sequence 23 from patent US 11400110
ATCATTTGAG
>OO402664.1 Sequence 22 from patent US 11400110
TTCATTTGAG
>OO402663.1 Sequence 20 from patent US 11400110
ACGATTTGAG
>OO268935.1 Sequence 1037 from patent US 11353400
AAAAAAAAAA
>OO267783.1 Sequence 4 from patent US 11352670
AGATCGGAAG
>OO267739.1 Sequence 36 from patent US 11352667
TAAGNNNAGA
>OO267738.1 Sequence 35 from patent US 11352667
TAATNNNAGA
>OO267737.1 Sequence 34 from patent US 11352667
TAACNNNAGA
>OO267736.1 Sequence 33 from patent US 11352667
TAAANNNAGA
>OO267733.1 Sequence 18 from patent US 11352667
AAANTNNAAA
>OO267732.1 Sequence 17 from patent US 11352667
AAANANNAAA
>OO267731.1 Sequence 16 from patent US 11352667
AAANGNNAAA
>OO267730.1 Sequence 15 from patent US 11352667
AAANCNNAAA
>OO267616.1 Sequence 1247 from patent US 11352666
TGGCTAATAA
>OO265662.1 Sequence 2 from patent US 11352659
TTAAGTACAA
>OO259695.1 Sequence 50 from patent US 11352626
CTTTCCTGGA
>OO259689.1 Sequence 44 from patent US 11352626
TCCAGGAAAG
>OO259162.1 Sequence 2 from patent US 11352620
NNNNGAGACG
>OO259161.1 Sequence 1 from patent US 11352620
CTCTTCNNNN
>OO254391.1 Sequence 37 from patent US 11345933
CCCGAAGAAC
>OO240599.1 Sequence 27 from patent US 11344633
GGGTTTTGGG
>OO240595.1 Sequence 23 from patent US 11344633
GGGTTTTGGG
>OO240467.1 Sequence 26 from patent US 11344610
GACGTACGTC
>OO232571.1 Sequence 24 from patent US 11339396
CCTGGCGGGG
>OO230753.1 Sequence 38 from patent US 11339391
CTCAGTAGGA
>OO230752.1 Sequence 37 from patent US 11339391
TGGTAACCTC
>OO230751.1 Sequence 36 from patent US 11339391
ACAGTCGTAG
>OO230750.1 Sequence 35 from patent US 11339391
GATCCGTACT
>OO230749.1 Sequence 34 from patent US 11339391
AGCTCAGTCA
>OO230748.1 Sequence 33 from patent US 11339391
CAGGTCTAAC
>OO230747.1 Sequence 32 from patent US 11339391
GTTCAGACTG
>OO230746.1 Sequence 31 from patent US 11339391
TCAAGTCGGT
>OO230745.1 Sequence 30 from patent US 11339391
GCTGTACAGA
>OO230744.1 Sequence 29 from patent US 11339391
TGACATGCTC
>OO230743.1 Sequence 28 from patent US 11339391
CACAGGTTAG
>OO230742.1 Sequence 27 from patent US 11339391
ATGTCCAGCT
>OO230741.1 Sequence 26 from patent US 11339391
TAGCGCATGA
>OO230740.1 Sequence 25 from patent US 11339391
ACCGATTGAC
>OO230739.1 Sequence 24 from patent US 11339391
CTTACGGATG
>OO230738.1 Sequence 23 from patent US 11339391
GGATTACCCT
>OO230737.1 Sequence 22 from patent US 11339391
AGTCTAGCCA
>OO230736.1 Sequence 21 from patent US 11339391
TCAGATCGTC
>OO230735.1 Sequence 20 from patent US 11339391
GACTCGATAG
>OO230734.1 Sequence 19 from patent US 11339391
CTGAGCTAGT
>OO230609.1 Sequence 19 from patent US 11339388
GATCCCTCGA
>OO230023.1 Sequence 21 from patent US 11339378
GSGSGSGSGS
>OO184033.1 Sequence 7 from patent US 11335558
CTGACTTCGG
>OO184032.1 Sequence 6 from patent US 11335558
GCGCGAGCGT
>OO184031.1 Sequence 5 from patent US 11335558
CCCACTTGGT
>OO184027.1 Sequence 7 from patent US 11335435
ACTACGACCC
>OO184026.1 Sequence 6 from patent US 11335435
TCGCCTGAGA
>OO184025.1 Sequence 5 from patent US 11335435
TTCGCTAACA
>OO184024.1 Sequence 4 from patent US 11335435
TCGCCTTAGC
>OO184023.1 Sequence 3 from patent US 11335435
ACTACGACTC
>OO184022.1 Sequence 2 from patent US 11335435
ACTACGACCA
>OO184021.1 Sequence 1 from patent US 11335435
GCCATATGGC
>OO183767.1 Sequence 388 from patent US 11332791
CGCGACCACT
>OO183766.1 Sequence 387 from patent US 11332791
CGCAACCACT
>OO183020.1 Sequence 1350 from patent US 11332761
AAGCCAAAAA
>OO172617.1 Sequence 21 from patent US 11332721
GGGGCAAACA
>OO172616.1 Sequence 20 from patent US 11332721
GGGGCAAATA
>OO169697.1 Sequence 2 from patent US 11326207
GGGGGGGGGA
>OO169696.1 Sequence 1 from patent US 11326207
TCCCCCCCCC
>OO169251.1 Sequence 17 from patent US 11326202
AGGCTTAGYY
>OO169250.1 Sequence 16 from patent US 11326202
TACTCCTTYY
>OO169249.1 Sequence 15 from patent US 11326202
TATGCAGTYY
>OO169248.1 Sequence 14 from patent US 11326202
CTCCTTACYY
>OO169247.1 Sequence 13 from patent US 11326202
TCTACTCTYY
>OO169246.1 Sequence 12 from patent US 11326202
AGAGGATAYY
>OO169245.1 Sequence 11 from patent US 11326202
ATAGAGAGYY
>OO169244.1 Sequence 10 from patent US 11326202
GCGATCTAYY
>OO169243.1 Sequence 9 from patent US 11326202
GCGATCTAYY
>OO162999.1 Sequence 121 from patent US 11326165
CAGGTAAGTA
>OO162998.1 Sequence 119 from patent US 11326165
CAAGTAAGTG
>OO162996.1 Sequence 117 from patent US 11326165
ATACTTACTG
>OO162955.1 Sequence 76 from patent US 11326165
TGGGTACCTG
>OO162954.1 Sequence 75 from patent US 11326165
GGGGTAAGTG
>OO162952.1 Sequence 73 from patent US 11326165
CAGGTAAGGC
>OO162951.1 Sequence 72 from patent US 11326165
AAGGTATGAG
>OO162950.1 Sequence 71 from patent US 11326165
TGGGTGGGTG
>OO162949.1 Sequence 70 from patent US 11326165
TGGGTGGGGG
>OO162948.1 Sequence 69 from patent US 11326165
TGGGTACCTG
>OO162946.1 Sequence 67 from patent US 11326165
GTTTTGGTGA
>OO162944.1 Sequence 65 from patent US 11326165
GTGGTAAGTG
>OO162943.1 Sequence 64 from patent US 11326165
GGGGTTGGGA
>OO162942.1 Sequence 63 from patent US 11326165
GGGGTGAGTG
>OO162941.1 Sequence 62 from patent US 11326165
GGGGTAAGTG
>OO162940.1 Sequence 61 from patent US 11326165
GCGGTGAGCT
>OO162939.1 Sequence 60 from patent US 11326165
GCGGTGAGCA
>OO162938.1 Sequence 59 from patent US 11326165
GCGGTAATCA
>OO162937.1 Sequence 58 from patent US 11326165
GAGGTGCGGG
>OO162936.1 Sequence 57 from patent US 11326165
GAGGTCTGGT
>OO162935.1 Sequence 56 from patent US 11326165
GAGGTAATGT
>OO162934.1 Sequence 55 from patent US 11326165
GAGGTAATAT
>OO162933.1 Sequence 54 from patent US 11326165
GAGGTAATAC
>OO162932.1 Sequence 53 from patent US 11326165
GAGGTAAGCG
>OO162931.1 Sequence 52 from patent US 11326165
GAGGTAAGAG
>OO162927.1 Sequence 48 from patent US 11326165
CTGGTGAGTC
>OO162925.1 Sequence 46 from patent US 11326165
CATGGAAGAC
>OO162924.1 Sequence 45 from patent US 11326165
CAGGTTTAGT
>OO162923.1 Sequence 44 from patent US 11326165
CAGGTGGGTG
>OO162921.1 Sequence 42 from patent US 11326165
CAGGTGAGGG
>OO162920.1 Sequence 41 from patent US 11326165
CAGGTCTGGT
>OO162919.1 Sequence 40 from patent US 11326165
CAGGTCTGGA
>OO162918.1 Sequence 39 from patent US 11326165
CAGGTCAGTG
>OO162915.1 Sequence 36 from patent US 11326165
CAGGTAGCAA
>OO162914.1 Sequence 35 from patent US 11326165
CAGGTACAGT
>OO162913.1 Sequence 34 from patent US 11326165
CAGGTAATGT
>OO162912.1 Sequence 33 from patent US 11326165
CAGGTAATGC
>OO162911.1 Sequence 32 from patent US 11326165
CAGGTAAGAC
>OO162909.1 Sequence 30 from patent US 11326165
CAGGTAAGGC
>OO162908.1 Sequence 29 from patent US 11326165
CAAGTAAGTA
>OO162907.1 Sequence 28 from patent US 11326165
CAAGGTACCT
>OO162906.1 Sequence 27 from patent US 11326165
ATCGGTAAAA
>OO162904.1 Sequence 25 from patent US 11326165
AGGGTAATGA
>OO162903.1 Sequence 24 from patent US 11326165
ACTGTGAGTG
>OO162902.1 Sequence 23 from patent US 11326165
ACGGTGAGTG
>OO162901.1 Sequence 22 from patent US 11326165
ACCGTGAGTT
>OO162900.1 Sequence 21 from patent US 11326165
AAGGTTAGTG
>OO162899.1 Sequence 20 from patent US 11326165
AAGGTGGGCC
>OO162898.1 Sequence 19 from patent US 11326165
AAGGTGAGTC
>OO162897.1 Sequence 18 from patent US 11326165
AAGGTGAGAT
>OO162895.1 Sequence 16 from patent US 11326165
AAGGTCTGGG
>OO162894.1 Sequence 15 from patent US 11326165
AAGGTATATT
>OO162893.1 Sequence 14 from patent US 11326165
AAGGTAGACC
>OO162891.1 Sequence 12 from patent US 11326165
AAGGTAATGT
>OO162890.1 Sequence 11 from patent US 11326165
AAGGTAATAA
>OO162889.1 Sequence 10 from patent US 11326165
AAGGTAAGCG
>OO162888.1 Sequence 9 from patent US 11326165
AAGGTAAGCC
>OO162886.1 Sequence 7 from patent US 11326165
AAGGTATGAG
>OO162885.1 Sequence 6 from patent US 11326165
AAGGCAGGGA
>OO162884.1 Sequence 5 from patent US 11326165
AAGGCAAGGG
>OO162883.1 Sequence 4 from patent US 11326165
AACATGAGGA
>OO162882.1 Sequence 3 from patent US 11326165
AAAGTGAGTT
>OO162881.1 Sequence 2 from patent US 11326165
AAAGTGAGTG
>OO162880.1 Sequence 1 from patent US 11326165
AAAGTAAGTA
>OO162805.1 Sequence 197 from patent US 11326162
NNNNNNNGTG
>OO162804.1 Sequence 196 from patent US 11326162
CACNNNNNNN
>OO162634.1 Sequence 61 from patent US 11326161
AAGCGCGNNN
>OO162629.1 Sequence 56 from patent US 11326161
AAGCGCGNNN
>OO160841.1 Sequence 31 from patent US 11324836
GACGATCGTC
>OO350687.1 Sequence 18 from patent US 11391744
GCCACATCCN
>OO350681.1 Sequence 6 from patent US 11391744
AAGTTTCCAA
>OO350354.1 Sequence 31 from patent US 11390909
GGATCNNNNN
>OO346673.1 Sequence 32 from patent US 11390867
CTTTCCACGC
>OO346667.1 Sequence 25 from patent US 11390867
CACGCACAGT
>OO346661.1 Sequence 17 from patent US 11390867
CTACGCTTTC
>OO346619.1 Sequence 113 from patent US 11390865
TACCAAGACG
>OO346112.1 Sequence 17 from patent US 11390844
CGCCAGGAGC
>OO346111.1 Sequence 16 from patent US 11390844
GGCCTCCACG
>OO346110.1 Sequence 15 from patent US 11390844
CACCTGCCGC
>OO346109.1 Sequence 14 from patent US 11390844
GCAGCAGCCG
>OO346108.1 Sequence 13 from patent US 11390844
GCACGCCGGA
>OO346107.1 Sequence 12 from patent US 11390844
ACCCCAGCCG
>OO346105.1 Sequence 10 from patent US 11390844
GGGCGACTAC
>OO346104.1 Sequence 9 from patent US 11390844
GTGATCGCAG
>OO346102.1 Sequence 7 from patent US 11390844
GGGTAACGCC
>OO346101.1 Sequence 6 from patent US 11390844
TGCCGAGCTG
>OO341804.1 Sequence 27 from patent US 11384396
CTTTGAAAGC
>OO340802.1 Sequence 3 from patent US 11384363
CTAACTGGGA
>OO340467.1 Sequence 405 from patent US 11384361
CAACACACAG
>OO340460.1 Sequence 398 from patent US 11384361
ACACACAGAG
>OO340457.1 Sequence 395 from patent US 11384361
TCAACACACA
>OO340454.1 Sequence 392 from patent US 11384361
ACACACAGAG
>OO340452.1 Sequence 390 from patent US 11384361
CAACACACAG
>OO340450.1 Sequence 388 from patent US 11384361
ACATACAGAG
>OO340448.1 Sequence 386 from patent US 11384361
AACATACAGA
>OO340447.1 Sequence 385 from patent US 11384361
CAACATACAG
>OO340446.1 Sequence 384 from patent US 11384361
TCAACATACA
>OO340442.1 Sequence 380 from patent US 11384361
CAACATACAG
>OO340441.1 Sequence 379 from patent US 11384361
TCAACATACA
>OO339757.1 Sequence 102 from patent US 11384357
NNAAAATGNN
>OO339756.1 Sequence 101 from patent US 11384357
GGTATGAAGN
>OO339580.1 Sequence 86 from patent US 11384355
ACCATCGAAT
>OO339578.1 Sequence 84 from patent US 11384355
CTATGATCAT
>OO339577.1 Sequence 82 from patent US 11384355
CAAGTTCCAT
>OO339543.1 Sequence 46 from patent US 11384355
ACCATCGAAT
>OO339541.1 Sequence 44 from patent US 11384355
CTATGATCAT
>OO339540.1 Sequence 42 from patent US 11384355
CAAGTTCCAT
>OO339347.1 Sequence 200 from patent US 11384353
GAAANNNNNN
>OO339191.1 Sequence 7 from patent US 11384346
GTGATCCCCC
>OO337714.1 Sequence 7 from patent US 11384338
GCCRCCATGG
>OO336943.1 Sequence 13 from patent US 11384123
GGAGGAAAAA
>OO336457.1 Sequence 37 from patent US 11382965
GCCRCCATGG
>OO332144.1 Sequence 54 from patent US 11377688
GGAAAGCTGC
>OO303545.1 Sequence 213 from patent US 11371101
TCCCGCTTCA
>OO303117.1 Sequence 92 from patent US 11371084
AAATAATAAT
>OO301942.1 Sequence 82 from patent US 11371062
AAAAAAAAAA
>OO301941.1 Sequence 81 from patent US 11371062
AAAAAAAAAA
>OO301940.1 Sequence 80 from patent US 11371062
AAAAAAAAAA
>OO301939.1 Sequence 79 from patent US 11371062
AAAAAAAAAA
>OO301938.1 Sequence 78 from patent US 11371062
AAAAAAAAAA
>OO301937.1 Sequence 77 from patent US 11371062
AAAAAAAAAA
>OO301936.1 Sequence 76 from patent US 11371062
AAAAAAAAAA
>OO301935.1 Sequence 75 from patent US 11371062
AAAAAAAAAA
>OO301934.1 Sequence 74 from patent US 11371062
AAAAAAAAAA
>OO301933.1 Sequence 73 from patent US 11371062
AAAAAAAAAA
>OO301932.1 Sequence 72 from patent US 11371062
AAAAAAAAAA
>OO301931.1 Sequence 71 from patent US 11371062
AAAAAAAAAA
>OO301930.1 Sequence 70 from patent US 11371062
AAAAAAAAAA
>OO301929.1 Sequence 69 from patent US 11371062
AAAAAAAAAA
>OO301928.1 Sequence 68 from patent US 11371062
AAAAAAAAAA
>OO301927.1 Sequence 67 from patent US 11371062
AAAAAAAAAA
>OO301926.1 Sequence 66 from patent US 11371062
AAAAAAAAAA
>OO301925.1 Sequence 65 from patent US 11371062
AAAAAAAAAA
>OO301924.1 Sequence 64 from patent US 11371062
AAAAAAAAAA
>OO301923.1 Sequence 63 from patent US 11371062
AAAAAAAAAA
>OO301922.1 Sequence 62 from patent US 11371062
AAAAAAAAAA
>OO301921.1 Sequence 61 from patent US 11371062
AAAAAAAAAA
>OO301920.1 Sequence 60 from patent US 11371062
AAAAAAAAAA
>OO301919.1 Sequence 59 from patent US 11371062
AAAAAAAAAA
>OO301918.1 Sequence 58 from patent US 11371062
AAAAAAAAAA
>OO301917.1 Sequence 57 from patent US 11371062
AAAAAAAAAA
>OO301916.1 Sequence 56 from patent US 11371062
AAAAAAAAAA
>OO301915.1 Sequence 55 from patent US 11371062
AAAAAAAAAA
>OO301914.1 Sequence 54 from patent US 11371062
AAAAAAAAAA
>OO301913.1 Sequence 53 from patent US 11371062
AAAAAAAAAA
>OO301912.1 Sequence 52 from patent US 11371062
AAAAAAAAAA
>OO301911.1 Sequence 51 from patent US 11371062
AAAAAAAAAA
>OO301910.1 Sequence 50 from patent US 11371062
AAAAAAAAAA
>OO301909.1 Sequence 49 from patent US 11371062
AAAAAAAAAA
>OO301908.1 Sequence 48 from patent US 11371062
AAAAAAAAAA
>OO301907.1 Sequence 47 from patent US 11371062
AAAAAAAAAA
>OO301906.1 Sequence 46 from patent US 11371062
AAAAAAAAAA
>OO301905.1 Sequence 45 from patent US 11371062
AAAAAAAAAA
>OO301904.1 Sequence 44 from patent US 11371062
AAAAAAAAAA
>OO301903.1 Sequence 43 from patent US 11371062
AAAAAAAAAA
>OO301902.1 Sequence 42 from patent US 11371062
AAAAAAAAAA
>OO301901.1 Sequence 41 from patent US 11371062
AAAAAAAAAA
>OO301900.1 Sequence 40 from patent US 11371062
AAAAAAAAAA
>OO301899.1 Sequence 39 from patent US 11371062
AAAAAAAAAA
>OO301898.1 Sequence 38 from patent US 11371062
AAAAAAAAAA
>OO301897.1 Sequence 37 from patent US 11371062
AAAAAAAAAA
>OO301890.1 Sequence 30 from patent US 11371062
AAAAAAAAAA
>OO301889.1 Sequence 29 from patent US 11371062
AAAAAAAAAA
>OO301888.1 Sequence 28 from patent US 11371062
AAAAAAAAAA
>OO301879.1 Sequence 19 from patent US 11371062
AAAAAAAAAA
>OO301878.1 Sequence 18 from patent US 11371062
AAAAAAAAAA
>OO301877.1 Sequence 17 from patent US 11371062
AAAAAAAAAA
>OO301614.1 Sequence 32 from patent US 11371051
TTACTGTCGA
>OO301288.1 Sequence 222 from patent US 11371045
CTGATTCTCA
>OO301207.1 Sequence 141 from patent US 11371045
YCNRCASSMY
>OO301206.1 Sequence 140 from patent US 11371045
RKSBTGSVGR
>OO301205.1 Sequence 139 from patent US 11371045
YYNRCASSMY
>OO301204.1 Sequence 138 from patent US 11371045
RKSBTSNVGR
>OO300742.1 Sequence 12 from patent US 11371041
AGCGGGAGGT
>OO300741.1 Sequence 11 from patent US 11371041
ACCTCCCGCT
>OO300485.1 Sequence 371 from patent US 11371031
TATATATATA
>OO300348.1 Sequence 231 from patent US 11371031
TTTTTTTTTT
>OO300139.1 Sequence 64 from patent US 11371023
NGCGTGGGCN
>OO300138.1 Sequence 63 from patent US 11371023
NGTGTGGGCN
>OO300137.1 Sequence 62 from patent US 11371023
NGGGTGGGCN
>OO300136.1 Sequence 61 from patent US 11371023
NGAGTGGGCN
>OO300135.1 Sequence 60 from patent US 11371023
NGNGTGGGCN
>OO295408.1 Sequence 14 from patent US 11365452
AGTCAGTCAG
>OO295405.1 Sequence 10 from patent US 11365452
TATGGTAATT
>OO283490.1 Sequence 68 from patent US 11364259
ACACACACAC
>OO283489.1 Sequence 67 from patent US 11364259
GTGTGTGTGT
>OO280647.1 Sequence 1 from patent US 11361159
GTATCCGAAA
>OO278393.1 Sequence 54 from patent US 11359208
TTTTTTTTTT
>OO270661.1 Sequence 29 from patent US 11359198
TTCCAAGGTT
>OO270660.1 Sequence 28 from patent US 11359198
AACCTTGGAA
>OO270595.1 Sequence 11 from patent US 11359191
GCCACCATGG
>OO270268.1 Sequence 99 from patent US 11359000
GCCACCATGG
>OO158238.1 Sequence 5 from patent US 11320376
AAAAAAAACC
>OO150090.1 Sequence 8 from patent US 11319594
ACCTGATGCA
>OO150089.1 Sequence 7 from patent US 11319594
CATGTCGATC
>OO150088.1 Sequence 6 from patent US 11319594
GTAACGCTAG
>OO150087.1 Sequence 5 from patent US 11319594
TGGCATACGT
>OO150086.1 Sequence 4 from patent US 11319594
CATCAGGTTT
>OO150085.1 Sequence 3 from patent US 11319594
TCGACATGGG
>OO150084.1 Sequence 2 from patent US 11319594
AGCGTTACCC
>OO150083.1 Sequence 1 from patent US 11319594
GTATGCCAAA
>OO149719.1 Sequence 24 from patent US 11319589
CGCATAGCGA
>OO149717.1 Sequence 22 from patent US 11319589
GGCATAGCGA
>OO149710.1 Sequence 15 from patent US 11319589
CGCATAGCGA
>OO148873.1 Sequence 106 from patent US 11319549
TCTAATTATT
>OO144273.1 Sequence 20 from patent US 11319350
TTTTTTTTTT
>OO144272.1 Sequence 19 from patent US 11319350
AAAAAAAAAA
>OO144271.1 Sequence 18 from patent US 11319350
ACCAGACAAA
>OO144270.1 Sequence 14 from patent US 11319350
ACCAGACAAA
>OO143661.1 Sequence 309 from patent US 11316812
ATAAGTCCAG
>OO143126.1 Sequence 734 from patent US 11315659
TTGCCCGGGC
>OO143122.1 Sequence 730 from patent US 11315659
TGCACAGGGC
>OO095272.1 Sequence 105 from patent US 11312965
TCGACGTCGA
>OO076408.1 Sequence 136 from patent US 11311574
GGGGTAGCGG
>pdb|8FOJ|P Chain P, Cryo-EM structure of S. cerevisiae DNA polymerase alpha-primase complex in the post RNA handoff state
NGGCGAGCAG
>OP959419.1 UNVERIFIED: Alternaria sp. isolate CS130 tef1 gene, partial sequence
GCCACAGCAC
>PA574217.1 WO 2023008451-A/8: Treatment and restoration method of pulmonary fibrosis
CTGGAGCCAG
>PA573982.1 JP 2023023890-A/14: Double-chained PNA probe
TGGCCCGCCC
>PA573981.1 JP 2023023890-A/13: Double-chained PNA probe
TGGCCCGCCC
>PA573980.1 JP 2023023890-A/12: Double-chained PNA probe
TGGCCCGCCC
>PA573979.1 JP 2023023890-A/11: Double-chained PNA probe
TGGCCCGCCC
>PA573978.1 JP 2023023890-A/10: Double-chained PNA probe
TGGCCCGCCC
>PA573977.1 JP 2023023890-A/9: Double-chained PNA probe
CTGCATGATG
>PA573976.1 JP 2023023890-A/8: Double-chained PNA probe
CTGCATGATG
>PA573975.1 JP 2023023890-A/7: Double-chained PNA probe
CTGCATGATG
>PA573974.1 JP 2023023890-A/6: Double-chained PNA probe
CTGCATGATG
>PA573973.1 JP 2023023890-A/5: Double-chained PNA probe
CTGCATGATG
>PA573719.1 JP 2023015421-A/44: Enhancer
GACACGTGGC
>PA573718.1 JP 2023015421-A/43: Enhancer
GCCACGTGAG
>PA573717.1 JP 2023015421-A/42: Enhancer
GCCACGTGCC
>PA573716.1 JP 2023015421-A/41: Enhancer
GTCACGTGCC
>PA573715.1 JP 2023015421-A/40: Enhancer
TCCACGTGGC
>PA573714.1 JP 2023015421-A/39: Enhancer
TACACGTGGC
>PA573713.1 JP 2023015421-A/38: Enhancer
AACACGTGTT
>PA573712.1 JP 2023015421-A/37: Enhancer
CTCACGTGAG
>PA573711.1 JP 2023015421-A/36: Enhancer
ATCACGTGAT
>PA573710.1 JP 2023015421-A/35: Enhancer
GGCACGTGCC
>PA573709.1 JP 2023015421-A/34: Enhancer
TACACGTGTA
>PA573708.1 JP 2023015421-A/33: Enhancer
GCCACGTGGC
>pdb|7UV7|F Chain F, Isoreticular, interpenetrating co-crystal of Replication Initiator Protein REPE54 and scaffold duplex (21mer) containing the cognate REPE54 sequence and an insert duplex (10mer) with guest TAMRA-labelled thymine and T-A rich sequence.
GTAATTACCG
>pdb|7UV7|E Chain E, Isoreticular, interpenetrating co-crystal of Replication Initiator Protein REPE54 and scaffold duplex (21mer) containing the cognate REPE54 sequence and an insert duplex (10mer) with guest TAMRA-labelled thymine and T-A rich sequence.
GACGGTAATT
>pdb|7MXW|B Chain B, Crystal structure of human exonuclease 1 Exo1 (WT) in complex with 5' flap DNA (uf1)
NCGACTAGCG
>pdb|7MXV|B Chain B, Crystal structure of human exonuclease 1 Exo1 (WT) in complex with 5' recessed-end DNA (ur)
NCGACTAGCG
>pdb|7MXR|B Chain B, Crystal structure of human exonuclease 1 Exo1 (WT) in complex with 5' recessed-end DNA (r-2)
NCGACTAGCG
>pdb|7MXQ|B Chain B, Crystal structure of human exonuclease 1 Exo1 (WT) in complex with 5' recessed-end DNA (r-1)
NCGACTAGCG
>pdb|7VPX|K Chain K, The cryo-EM structure of the human pre-A complex
GGGTGAGTAC
>pdb|7UV6|F Chain F, Isoreticular, interpenetrating co-crystal of Replication Initiator Protein REPE54 and scaffold duplex (21mer) containing the cognate REPE54 sequence and an insert duplex (10mer) with guest TAMRA-labelled thymine and G-C rich sequence.
GTCCGGGCCG
>pdb|7UV6|E Chain E, Isoreticular, interpenetrating co-crystal of Replication Initiator Protein REPE54 and scaffold duplex (21mer) containing the cognate REPE54 sequence and an insert duplex (10mer) with guest TAMRA-labelled thymine and G-C rich sequence.
GACGGCCCGG
>PA571408.1 JP 2023003315-A/16: Coronavirus vaccines
AGGGTGAAAG
>PA571407.1 JP 2023003315-A/15: Coronavirus vaccines
AGGGTGAATG
>PA571406.1 JP 2023003315-A/14: Coronavirus vaccines
AGGGTCAAAG
>PA571405.1 JP 2023003315-A/13: Coronavirus vaccines
CTTTCACCCT
>PA571404.1 JP 2023003315-A/12: Coronavirus vaccines
CATTCACCCT
>PA571403.1 JP 2023003315-A/11: Coronavirus vaccines
CTTTGACCCT
>PA571402.1 JP 2023003315-A/10: Coronavirus vaccines
CWTTVWCCCT
>PA571382.1 JP 2023000571-A/1: Method of purifying a terminal-modified target nucleic acid
ATGTANTGCG
>pdb|5ODP|P Chain P, Salinibacter ruber Single-Strand Binding protein D17K D71K mutant
NTTTTTTTTT
>pdb|5ODP|O Chain O, Salinibacter ruber Single-Strand Binding protein D17K D71K mutant
NTTTTTTTTT
>pdb|5ODP|N Chain N, Salinibacter ruber Single-Strand Binding protein D17K D71K mutant
TTTTTTTTTT
>pdb|5ODP|M Chain M, Salinibacter ruber Single-Strand Binding protein D17K D71K mutant
NTTTTTTTTT
>pdb|5ODP|L Chain L, Salinibacter ruber Single-Strand Binding protein D17K D71K mutant
TTTTTTTTTT
>pdb|7XM0|I Chain I, Crystal structure of Sau3AI-C and DNA substrate complex
CATGATCATG
>pdb|7XM0|H Chain H, Crystal structure of Sau3AI-C and DNA substrate complex
CATGATCATG
>pdb|7XM0|G Chain G, Crystal structure of Sau3AI-C and DNA substrate complex
CATGATCATG
>pdb|7XM0|F Chain F, Crystal structure of Sau3AI-C and DNA substrate complex
CATGATCATG
>pdb|7XM0|E Chain E, Crystal structure of Sau3AI-C and DNA substrate complex
CATGATCATG
>pdb|7XM0|D Chain D, Crystal structure of Sau3AI-C and DNA substrate complex
CATGATCATG
>OO076188.1 Sequence 309 from patent US 11310180
ATAAGTCCAG
>OO076067.1 Sequence 309 from patent US 11310179
ATAAGTCCAG
>OO074509.1 Sequence 74 from patent US 11306355
CCTGTCGAGC
>OO074508.1 Sequence 73 from patent US 11306355
CCTGTTGAGC
>OO074507.1 Sequence 72 from patent US 11306355
CCTGTNGAGC
>OO074506.1 Sequence 71 from patent US 11306355
AGTCTNGATC
>OO074505.1 Sequence 70 from patent US 11306355
AGTCTTGATC
>OO074504.1 Sequence 69 from patent US 11306355
CCTGTTGAGC
>OO074503.1 Sequence 68 from patent US 11306355
CCTGTCGAGC
>OO074502.1 Sequence 67 from patent US 11306355
CCTGTNGAGC
>OO074380.1 Sequence 19 from patent US 11306349
ATATATATAT
>OO065386.1 Sequence 309 from patent US 11303594
ATAAGTCCAG
>OO065265.1 Sequence 309 from patent US 11303593
ATAAGTCCAG
>OO065144.1 Sequence 309 from patent US 11303592
ATAAGTCCAG
>OO064846.1 Sequence 83 from patent US 11300509
AAAAAAAAAA
>OO064721.1 Sequence 6 from patent US 11299777
TTATACCGCT
>OO064720.1 Sequence 5 from patent US 11299777
AGGCTTATGG
>OO064718.1 Sequence 3 from patent US 11299777
GCTTATGGAG
>OO064717.1 Sequence 2 from patent US 11299777
ATACCGCTTA
>OO063082.1 Sequence 19 from patent US 11299735
CNCACCNGGA
>OO063075.1 Sequence 9 from patent US 11299735
NCACCNGGAG
>OO062973.1 Sequence 182 from patent US 11299732
TTAATGAGAT
>OO062972.1 Sequence 181 from patent US 11299732
GTTTACTGTG
>OO061271.1 Sequence 13 from patent US 11298411
TCTTTAAAGT
>OO061269.1 Sequence 11 from patent US 11298411
TCTTTTGGAA
>OO061268.1 Sequence 10 from patent US 11298411
TCTTTAAAGT
>OO061266.1 Sequence 8 from patent US 11298411
TCTTTTGGAA
>OO061265.1 Sequence 7 from patent US 11298411
TCTTTAAAGT
>OO061263.1 Sequence 5 from patent US 11298411
TCTTTTGGAA
>OO059108.1 Sequence 50 from patent US 11297810
GGGCTGGGCT
>OO059090.1 Sequence 20 from patent US 11297810
GGGCTGGGCT
>OO059089.1 Sequence 19 from patent US 11297810
GGGGTGGGGT
>OO059088.1 Sequence 18 from patent US 11297810
GAGCTGAGCT
>OO010520.1 Sequence 1350 from patent US 11293034
AAGCCAAAAA
>OO003962.1 Sequence 115 from patent US 11293019
GTGCGGCCGC
>OO003961.1 Sequence 114 from patent US 11293019
GCGGCCGCAC
>OO002542.1 Sequence 13 from patent US 11291710
TCTTTAAAGT
>OO002540.1 Sequence 11 from patent US 11291710
TCTTTTGGAA
>OO002539.1 Sequence 10 from patent US 11291710
TCTTTAAAGT
>OO002537.1 Sequence 8 from patent US 11291710
TCTTTTGGAA
>OO002536.1 Sequence 7 from patent US 11291710
TCTTTAAAGT
>OO002534.1 Sequence 5 from patent US 11291710
TCTTTTGGAA
>MY953419.1 Sequence 88 from patent US 11286519
CAGGTACCAT
>MY953418.1 Sequence 87 from patent US 11286519
CAGCTACCAT
>MY953331.1 Sequence 327 from patent US 11286518
GCCGCGGTAA
>MY953330.1 Sequence 326 from patent US 11286518
CTACTTATCG
>MY953329.1 Sequence 325 from patent US 11286518
ATGGCTAGGG
>MY953328.1 Sequence 324 from patent US 11286518
TGACTGTCGC
>MY953327.1 Sequence 323 from patent US 11286518
ACTGATCGCT
>MY953002.1 Sequence 5 from patent US 11286517
TTCTCTTATT
>MY952998.1 Sequence 1 from patent US 11286517
ATCTCTTATT
>MY946493.1 Sequence 39 from patent US 11286482
CAGGTAAGTA
>MY946464.1 Sequence 3 from patent US 11286479
CGCCACCCAC
>MY946463.1 Sequence 2 from patent US 11286479
GAGAGAGGTC
>MY946462.1 Sequence 1 from patent US 11286479
TAGTATAAGA
>MY945433.1 Sequence 13 from patent US 11285193
TCTTTAAAGT
>MY945431.1 Sequence 11 from patent US 11285193
TCTTTTGGAA
>MY945430.1 Sequence 10 from patent US 11285193
TCTTTAAAGT
>MY945428.1 Sequence 8 from patent US 11285193
TCTTTTGGAA
>MY945427.1 Sequence 7 from patent US 11285193
TCTTTAAAGT
>MY945425.1 Sequence 5 from patent US 11285193
TCTTTTGGAA
>MY944939.1 Sequence 7 from patent US 11281856
GTTAATCGGC
>MY944938.1 Sequence 6 from patent US 11281856
TGTGGGGTTA
>MY944937.1 Sequence 5 from patent US 11281856
ATCTGTGGGG
>MY944429.1 Sequence 99 from patent US 11279969
TTCACTGTAG
>MY944427.1 Sequence 97 from patent US 11279969
AGCTTCTTAT
>MY944332.1 Sequence 2 from patent US 11279969
AACACCACCT
>MY939451.1 Sequence 30 from patent US 11279927
TGTCAATGGG
>MY939450.1 Sequence 29 from patent US 11279927
TGCCATAGGG
>MY939449.1 Sequence 28 from patent US 11279927
TGATACTGGG
>MY939448.1 Sequence 27 from patent US 11279927
TCTCTCTGGG
>MY939447.1 Sequence 26 from patent US 11279927
TCAATTAGGG
>MY939446.1 Sequence 25 from patent US 11279927
TCTGCCTGGG
>MY939445.1 Sequence 24 from patent US 11279927
TACACTAGGG
>MY939444.1 Sequence 23 from patent US 11279927
TTGTGCTGGG
>MY939443.1 Sequence 22 from patent US 11279927
TTGATATGGG
>MY939416.1 Sequence 1415 from patent US 11279926
GATCCAGTAC
>MY939415.1 Sequence 1414 from patent US 11279926
GTACTGGATC
>MY937558.1 Sequence 57 from patent US 11279769
GCCRCCATGG
>MY937354.1 Sequence 14 from patent US 11279745
GCCRCCATGG
>MY936665.1 Sequence 13 from patent US 11279742
GCCACCATGG
>MY936586.1 Sequence 12 from patent US 11279736
TCANACATGC
>MY936585.1 Sequence 11 from patent US 11279736
TCANACATGC
>MY936579.1 Sequence 5 from patent US 11279736
GCATGTTTGA
>MY936578.1 Sequence 4 from patent US 11279736
GCATGTTTGA
>MY936577.1 Sequence 3 from patent US 11279736
GCATGTTTGA
>MY936576.1 Sequence 2 from patent US 11279736
GCATGTTTGA
>MY936575.1 Sequence 1 from patent US 11279736
GCATGTTTGA
>MY936530.1 Sequence 8 from patent US 11279708
AGAGAGAGAG
>MY935898.1 Sequence 82 from patent US 11278570
ATGCNTAGAT
>MY930007.1 Sequence 13 from patent US 11275081
GGTACCTCTA
>MY930006.1 Sequence 12 from patent US 11275081
GCCGTGACTA
>MY930005.1 Sequence 11 from patent US 11275081
GGGGTCGCCG
>MY929995.1 Sequence 1 from patent US 11275081
ATATATGTAA
>MY929821.1 Sequence 1336 from patent US 11274350
AGGAGGAGGG
>MY917813.1 Sequence 19 from patent US 11274333
AAGGGCGATC
>MY917182.1 Sequence 1350 from patent US 11274318
AAGCCAAAAA
>MY916645.1 Sequence 123 from patent US 11274317
TTTAATTCTG
>MY915482.1 Sequence 15 from patent US 11274303
TATACGCGCA
>MY915470.1 Sequence 3 from patent US 11274303
ACTTACCCGA
>MY915469.1 Sequence 2 from patent US 11274303
ACATGCATCC
>MY914485.1 Sequence 19 from patent US 11274134
GGGGATTCCC
>MY914484.1 Sequence 18 from patent US 11274134
GGGAATTTCC
>MY914483.1 Sequence 17 from patent US 11274134
GGGAATTCCC
>MY914481.1 Sequence 15 from patent US 11274134
AGGGAAGTTA
>MY914477.1 Sequence 11 from patent US 11274134
GGGRNNYYCC
>MY914476.1 Sequence 10 from patent US 11274134
NGGNNWTTCC
>MY914475.1 Sequence 9 from patent US 11274134
GGGRNTTTCC
>MY914474.1 Sequence 8 from patent US 11274134
GGGGATYCCC
>MY914472.1 Sequence 6 from patent US 11274134
GGRRNNYYCC
>MY914471.1 Sequence 5 from patent US 11274134
GGGRNYYYCC
>MY914100.1 Sequence 176 from patent US 11273442
ATTATTATTA
>MY914065.1 Sequence 12 from patent US 11273442
TTTTTTTTTT
>MY914064.1 Sequence 4 from patent US 11273442
TTTTTTTTTT
>MY914063.1 Sequence 3 from patent US 11273442
TTTTTTTTTT
>MY913995.1 Sequence 15 from patent US 11273214
AGGAGCAAAG
>MY913994.1 Sequence 14 from patent US 11273214
AGGAGTAAAG
>MY913993.1 Sequence 13 from patent US 11273214
AGGACAAAAG
>MY913992.1 Sequence 12 from patent US 11273214
AGGATTAAAG
>MY913698.1 Sequence 13 from patent US 11273173
TGTGAGGATT
>MY913697.1 Sequence 12 from patent US 11273173
TGTGAGGATT
>MY913696.1 Sequence 11 from patent US 11273173
AATCCTCACA
>MY913389.1 Sequence 179 from patent US 11268159
CCACCCCCAT
>MY913327.1 Sequence 117 from patent US 11268159
CCAGTANCAG
>MY913204.1 Sequence 21 from patent US 11268157
CCRNCCATGG
>MY911489.1 Sequence 6 from patent US 11268136
CTTAGCTGCA
>MY910868.1 Sequence 11 from patent US 11268115
ATCGGATCCA
>MY910392.1 Sequence 75 from patent US 11268099
CGGGTACGGG
>MY910322.1 Sequence 5 from patent US 11268099
CGGGTACGGG
>MY910290.1 Sequence 58 from patent US 11268098
ACGACGTCGT
>MY910288.1 Sequence 56 from patent US 11268098
GACGATCGTC
>MY909156.1 Sequence 6 from patent US 11268093
CAGCAGCAGC
>MY908772.1 Sequence 7 from patent US 11268087
AAAAAAAAAA
>MY908768.1 Sequence 3 from patent US 11268087
TTTTTTTTTT
>MY901116.1 Sequence 721 from patent US 11266655
CCATAAATCA
>MY901040.1 Sequence 645 from patent US 11266655
DGGGYGKGGC
>MY901034.1 Sequence 639 from patent US 11266655
SCTMATTANN
>MY901029.1 Sequence 634 from patent US 11266655
NYTMATTANN
>MY901023.1 Sequence 628 from patent US 11266655
NTTRCGCAAY
>MY901022.1 Sequence 627 from patent US 11266655
NTTRCGCAAY
>MY901021.1 Sequence 626 from patent US 11266655
NTTRCGCAAY
>MY901020.1 Sequence 625 from patent US 11266655
NTTRCGCAAY
>MY901010.1 Sequence 615 from patent US 11266655
NTATYGATCH
>MY900999.1 Sequence 604 from patent US 11266655
NSCTMATTAN
>MY900986.1 Sequence 591 from patent US 11266655
NRMATWCCWN
>MY900983.1 Sequence 588 from patent US 11266655
NNTNATTANN
>MY900982.1 Sequence 587 from patent US 11266655
NNTNATTANN
>MY900967.1 Sequence 572 from patent US 11266655
NHAACBGYYV
>MY900950.1 Sequence 555 from patent US 11266655
NCCACTTRAN
>MY900940.1 Sequence 545 from patent US 11266655
NACAYATGNN
>MY900936.1 Sequence 541 from patent US 11266655
NAACCRCAAN
>MY900919.1 Sequence 524 from patent US 11266655
RTGTACGGRT
>MY900913.1 Sequence 518 from patent US 11266655
RRACGCSAAA
>MY900900.1 Sequence 505 from patent US 11266655
NGYAATAAAA
>MY900899.1 Sequence 504 from patent US 11266655
NCYAATAAAA
>MY900894.1 Sequence 499 from patent US 11266655
DATGASTCAT
>MY900890.1 Sequence 495 from patent US 11266655
WATGCGCATW
>MY900889.1 Sequence 494 from patent US 11266655
VCAGCTGBNN
>MY900888.1 Sequence 493 from patent US 11266655
RTCACGTGAY
>MY900887.1 Sequence 492 from patent US 11266655
RTCACGTGAY
>MY900886.1 Sequence 491 from patent US 11266655
RTCACGTGAY
>MY900885.1 Sequence 490 from patent US 11266655
RTCACGTGAY
>MY900878.1 Sequence 483 from patent US 11266655
RACATATGTY
>MY900876.1 Sequence 481 from patent US 11266655
NYTAGTTAMN
>MY900875.1 Sequence 480 from patent US 11266655
NYTAATTARN
>MY900872.1 Sequence 477 from patent US 11266655
NSTAATTANN
>MY900871.1 Sequence 476 from patent US 11266655
NSTAATTANN
>MY900870.1 Sequence 475 from patent US 11266655
NSTAATTANN
>MY900869.1 Sequence 474 from patent US 11266655
NRYTTCCGGH
>MY900864.1 Sequence 469 from patent US 11266655
NRCATTCCWN
>MY900863.1 Sequence 468 from patent US 11266655
NRCACCTGNN
>MY900859.1 Sequence 464 from patent US 11266655
NNYMATTANN
>MY900858.1 Sequence 463 from patent US 11266655
NNYMATTANN
>MY900857.1 Sequence 462 from patent US 11266655
NNYMATTANN
>MY900856.1 Sequence 461 from patent US 11266655
NNYMATTANN
>MY900855.1 Sequence 460 from patent US 11266655
NNYMATTANN
>MY900854.1 Sequence 459 from patent US 11266655
NNYMATTANN
>MY900853.1 Sequence 458 from patent US 11266655
NNYMATTANN
>MY900852.1 Sequence 457 from patent US 11266655
NNYAATTANN
>MY900851.1 Sequence 456 from patent US 11266655
NNYAATTANN
>MY900850.1 Sequence 455 from patent US 11266655
NNYAATTANN
>MY900849.1 Sequence 454 from patent US 11266655
NNYAATTANN
>MY900848.1 Sequence 453 from patent US 11266655
NNYAATTANN
>MY900847.1 Sequence 452 from patent US 11266655
NNYAATTANN
>MY900846.1 Sequence 451 from patent US 11266655
NNYAATTANN
>MY900845.1 Sequence 450 from patent US 11266655
NNYAATTANN
>MY900844.1 Sequence 449 from patent US 11266655
NNYAATTANN
>MY900843.1 Sequence 448 from patent US 11266655
NNYAATTANN
>MY900842.1 Sequence 447 from patent US 11266655
NNYAATTANN
>MY900841.1 Sequence 446 from patent US 11266655
NNYAATTANN
>MY900840.1 Sequence 445 from patent US 11266655
NNYAATTANN
>MY900839.1 Sequence 444 from patent US 11266655
NNYAATTANN
>MY900836.1 Sequence 441 from patent US 11266655
NNTGCCAANN
>MY900834.1 Sequence 439 from patent US 11266655
NNTAATTRNN
>MY900833.1 Sequence 438 from patent US 11266655
NNTAATTGNN
>MY900832.1 Sequence 437 from patent US 11266655
NNTAATTANN
>MY900831.1 Sequence 436 from patent US 11266655
NNTAATCCNN
>MY900830.1 Sequence 435 from patent US 11266655
NNTAATCCNN
>MY900828.1 Sequence 433 from patent US 11266655
NNTAAACGNN
>MY900821.1 Sequence 426 from patent US 11266655
NNGGATTANN
>MY900820.1 Sequence 425 from patent US 11266655
NNGGATTANN
>MY900815.1 Sequence 420 from patent US 11266655
NNCATATGNN
>MY900814.1 Sequence 419 from patent US 11266655
NNCATATGNN
>MY900813.1 Sequence 418 from patent US 11266655
NNCACGTGNN
>MY900812.1 Sequence 417 from patent US 11266655
NNCACGTGNN
>MY900811.1 Sequence 416 from patent US 11266655
NNCACGTGNN
>MY900810.1 Sequence 415 from patent US 11266655
NNCACGTGNN
>MY900809.1 Sequence 414 from patent US 11266655
NNCACCTGNN
>MY900808.1 Sequence 413 from patent US 11266655
NNCACCTGNN
>MY900807.1 Sequence 412 from patent US 11266655
NNCACCTGNN
>MY900806.1 Sequence 411 from patent US 11266655
NNCACCTGNN
>MY900805.1 Sequence 410 from patent US 11266655
NNCACCTGCN
>MY900797.1 Sequence 402 from patent US 11266655
NKCACGTGMN
>MY900796.1 Sequence 401 from patent US 11266655
NKCACGTGMN
>MY900785.1 Sequence 390 from patent US 11266655
NCTAATTANN
>MY900779.1 Sequence 384 from patent US 11266655
NATGCGGGTN
>MY900767.1 Sequence 372 from patent US 11266655
NACACGTGTN
>MY900766.1 Sequence 371 from patent US 11266655
NAACCGGTTN
>MY900765.1 Sequence 370 from patent US 11266655
NAACCGGTTN
>MY900764.1 Sequence 369 from patent US 11266655
NAACCGCAAN
>MY900762.1 Sequence 367 from patent US 11266655
KSYGGAAGTN
>MY900760.1 Sequence 365 from patent US 11266655
HAATAAAGNN
>MY900758.1 Sequence 363 from patent US 11266655
YGTCTAGACA
>MY900757.1 Sequence 362 from patent US 11266655
WWWWSYGGGG
>MY900756.1 Sequence 361 from patent US 11266655
WDNCTGGGCA
>MY900753.1 Sequence 358 from patent US 11266655
RTCATGTGAC
>MY900746.1 Sequence 351 from patent US 11266655
RCCGGAAGTG
>MY900742.1 Sequence 347 from patent US 11266655
NNCACGTGCC
>MY900740.1 Sequence 345 from patent US 11266655
NCCCCCCCAC
>MY900739.1 Sequence 344 from patent US 11266655
NATGCGGGTA
>MY900738.1 Sequence 343 from patent US 11266655
NAGGTGTGAA
>MY900735.1 Sequence 340 from patent US 11266655
KCCACGTGAC
>MY900722.1 Sequence 327 from patent US 11266655
TGYAYGGRTG
>MY900689.1 Sequence 294 from patent US 11266655
GTTGYCATGG
>MY900684.1 Sequence 289 from patent US 11266655
GNCACGTGNC
>MY900675.1 Sequence 280 from patent US 11266655
AWCAGCTGWT
>MY900672.1 Sequence 277 from patent US 11266655
ANCATATGNT
>MY900671.1 Sequence 276 from patent US 11266655
ANCATATGNT
>MY900670.1 Sequence 275 from patent US 11266655
AMCATATGKT
>MY900669.1 Sequence 274 from patent US 11266655
AMCATATGKT
>MY900668.1 Sequence 273 from patent US 11266655
AKGMCACGTA
>MY900659.1 Sequence 264 from patent US 11266655
TSAAGGTCAN
>MY900658.1 Sequence 263 from patent US 11266655
TRTTTACTTW
>MY900657.1 Sequence 262 from patent US 11266655
TAATCRATAN
>MY900656.1 Sequence 261 from patent US 11266655
TAATCRATAN
>MY900654.1 Sequence 259 from patent US 11266655
GTCGTWAAAN
>MY900653.1 Sequence 258 from patent US 11266655
GTCGTWAAAN
>MY900651.1 Sequence 256 from patent US 11266655
GTAATWAAAN
>MY900650.1 Sequence 255 from patent US 11266655
GNCACGTGYN
>MY900646.1 Sequence 251 from patent US 11266655
CYAATAAAAN
>MY900643.1 Sequence 248 from patent US 11266655
CCWGGAATGY
>MY900642.1 Sequence 247 from patent US 11266655
CCWGGAATGY
>MY900640.1 Sequence 245 from patent US 11266655
CCCATWAAAN
>MY900635.1 Sequence 240 from patent US 11266655
ACCGGAWGYN
>MY900633.1 Sequence 238 from patent US 11266655
ACCGGAARTN
>MY900632.1 Sequence 237 from patent US 11266655
ACCGGAARTN
>MY900628.1 Sequence 233 from patent US 11266655
TTTTATKRGG
>MY900619.1 Sequence 224 from patent US 11266655
TTCCKNAGAA
>MY900618.1 Sequence 223 from patent US 11266655
TRNGTAAACA
>MY900617.1 Sequence 222 from patent US 11266655
TGGAACAGMA
>MY900600.1 Sequence 205 from patent US 11266655
TAATYRATTA
>MY900599.1 Sequence 204 from patent US 11266655
TAATYRATTA
>MY900592.1 Sequence 197 from patent US 11266655
GNCCACGTGG
>MY900585.1 Sequence 190 from patent US 11266655
GAGSCCGAGC
>MY900582.1 Sequence 187 from patent US 11266655
CWGGCGGGAA
>MY900579.1 Sequence 184 from patent US 11266655
AVCAGGAAGT
>MY900570.1 Sequence 175 from patent US 11266655
ANACAGCTGC
>MY900563.1 Sequence 168 from patent US 11266655
ACVAGGAAGT
>MY900552.1 Sequence 157 from patent US 11266655
AACAVBTGTT
>MY900541.1 Sequence 146 from patent US 11266655
GGCGGGAARN
>MY900540.1 Sequence 145 from patent US 11266655
GGCGGGAAAH
>MY900538.1 Sequence 143 from patent US 11266655
CCAATAAAAN
>MY900537.1 Sequence 142 from patent US 11266655
CCAATAAAAN
>MY900536.1 Sequence 141 from patent US 11266655
CCAATAAAAN
>MY900535.1 Sequence 140 from patent US 11266655
AGGTGTGANN
>MY900534.1 Sequence 139 from patent US 11266655
ACCGGAARYN
>MY900533.1 Sequence 138 from patent US 11266655
ACCGGAARYN
>MY900532.1 Sequence 137 from patent US 11266655
ACCGGAARYN
>MY900531.1 Sequence 136 from patent US 11266655
ACCGGAAGTN
>MY900530.1 Sequence 135 from patent US 11266655
ACCGGAAGTN
>MY900529.1 Sequence 134 from patent US 11266655
ACCGGAAGTN
>MY900528.1 Sequence 133 from patent US 11266655
ACCGGAAGTN
>MY900527.1 Sequence 132 from patent US 11266655
ACCGGAAGTN
>MY900526.1 Sequence 131 from patent US 11266655
ACCGGAAGTN
>MY900525.1 Sequence 130 from patent US 11266655
ACCGGAAGTN
>MY900507.1 Sequence 112 from patent US 11266655
TGGCAGTTGG
>MY900502.1 Sequence 107 from patent US 11266655
GTGGGCCCCA
>MY900499.1 Sequence 104 from patent US 11266655
GTCACGTGAC
>MY900498.1 Sequence 103 from patent US 11266655
GTCACGTGAC
>MY900497.1 Sequence 102 from patent US 11266655
GTACCTACCT
>MY900491.1 Sequence 96 from patent US 11266655
GGTCACGTGA
>MY900483.1 Sequence 88 from patent US 11266655
GATTGCATCA
>MY900476.1 Sequence 81 from patent US 11266655
CGGTTTCAAA
>MY900474.1 Sequence 79 from patent US 11266655
CGGACACAAT
>MY900473.1 Sequence 78 from patent US 11266655
CGCAGCTGCG
>MY900469.1 Sequence 74 from patent US 11266655
ATTGCGCAAC
>MY900467.1 Sequence 72 from patent US 11266655
ATGACTCATC
>MY900466.1 Sequence 71 from patent US 11266655
ATGACGTCAT
>MY900463.1 Sequence 68 from patent US 11266655
ATCACGTGAT
>MY900462.1 Sequence 67 from patent US 11266655
ATCACGTGAT
>MY900455.1 Sequence 60 from patent US 11266655
AGAGGAAGTG
>MY900452.1 Sequence 57 from patent US 11266655
ACTGAAACCA
>MY900450.1 Sequence 55 from patent US 11266655
ACCGAACAAT
>MY900448.1 Sequence 53 from patent US 11266655
ACATCCTGGT
>MY900447.1 Sequence 52 from patent US 11266655
ACAGGAAGTG
>MY900446.1 Sequence 51 from patent US 11266655
ACAGGAAGTG
>MY900442.1 Sequence 47 from patent US 11266655
AACCGGAAGT
>MY900441.1 Sequence 46 from patent US 11266655
AACCGGAAGT
>MY900440.1 Sequence 45 from patent US 11266655
AACCGGAAGT
>MY900439.1 Sequence 44 from patent US 11266655
AACATCTGGA
>MY900438.1 Sequence 43 from patent US 11266655
AACAGCTGTT
>MY900436.1 Sequence 41 from patent US 11266655
AAAGTAAACA
>MY900435.1 Sequence 40 from patent US 11266655
AAACCACAAA
>MY898770.1 Sequence 12 from patent US 11261448
CCATGATCCT
>MY893160.1 Sequence 19 from patent US 11261217
NNCAGGAGNN
>MY893159.1 Sequence 18 from patent US 11261217
NNTGGAGGNN
>MY893158.1 Sequence 17 from patent US 11261217
NNGAGGAANN
>MY893157.1 Sequence 16 from patent US 11261217
NNGAGGAGNN
>MY893156.1 Sequence 15 from patent US 11261217
NNAGGACTNN
>MY893155.1 Sequence 14 from patent US 11261217
NNGGAGATNN
>MY887846.1 Sequence 17 from patent US 11259509
GAATTCAAGN
>MY887721.1 Sequence 15 from patent US 11255847
ATCCTAGCAA
>MY886735.1 Sequence 6 from patent US 11254981
TTTTTTTTTT
>MY885766.1 Sequence 19 from patent US 11254961
CTACTGACTG
>MY885765.1 Sequence 18 from patent US 11254961
CTACTGACTG
>MY881537.1 Sequence 46 from patent US 11253608
TTCCGTGGCG
>MY881506.1 Sequence 4 from patent US 11253608
GGTGTTTTGG
>MY867199.1 Sequence 140 from patent US 11253589
TYAAGTNNTT
>MY867179.1 Sequence 120 from patent US 11253589
ACAAGTGCTT
>MY867141.1 Sequence 82 from patent US 11253589
ACAAGTATTT
>MY867140.1 Sequence 81 from patent US 11253589
TTAGGTGGTT
>MY867136.1 Sequence 77 from patent US 11253589
TTAAGTCTTT
>MY867131.1 Sequence 72 from patent US 11253589
TTAAGGGGTT
>MY861564.1 Sequence 10 from patent US 11248221
CAATATTAAA
>MY861563.1 Sequence 9 from patent US 11248221
GGATCCGCTG
>MY843073.1 Sequence 17 from patent US 11242561
CATGCTAGTA
>MY843072.1 Sequence 16 from patent US 11242561
CATGCTAGTA
>MY843071.1 Sequence 15 from patent US 11242561
CATGCGAGAT
>MY843069.1 Sequence 13 from patent US 11242561
CATGCTAGTA
>MY843068.1 Sequence 12 from patent US 11242561
CATGCTAGTA
>MY843066.1 Sequence 10 from patent US 11242561
CATGCGAGAT
>MY843065.1 Sequence 9 from patent US 11242561
CATGCGAGAT
>MY843043.1 Sequence 9 from patent US 11242554
TTTTAATTTT
>MY842104.1 Sequence 1350 from patent US 11242543
AAGCCAAAAA
>MY808608.1 Sequence 102 from patent US 11237165
GCCACCATGG
>MY802793.1 Sequence 11 from patent US 11236326
WNGGCGGCWW
>MY801862.1 Sequence 10 from patent US 11236137
GCCACCATGG
>MY801283.1 Sequence 34 from patent US 11235025
GGGAATTTCC
>MY798337.1 Sequence 5 from patent US 11230713
GCTGCCGGGA
>pdb|8BWS|R Chain R, Structure of yeast RNA Polymerase III elongation complex at 3.3 A
ATCGAGAGGA
>pdb|7Z2Z|R Chain R, Structure of yeast RNA Polymerase III-DNA-Ty1 integrase complex (Pol III-DNA-IN1) at 3.1 A
ATCGAGAGGA
>pdb|7SPL|C Chain C, [2T3] Self-assembling 3D DNA triangle with three inter-junction base pairs containing the L1 junction and a zero-linked center strand
NGACAGTAGA
>PA566218.1 WO 2022270585-A/210: Combination of antisense oligomers
AACAGTGTGC
>PA566217.1 WO 2022270585-A/209: Combination of antisense oligomers
AAACAGTGTG
>PA566216.1 WO 2022270585-A/208: Combination of antisense oligomers
TAAACAGTGT
>PA566215.1 WO 2022270585-A/207: Combination of antisense oligomers
TTAAACAGTG
>PA566214.1 WO 2022270585-A/206: Combination of antisense oligomers
ATTAAACAGT
>PA566213.1 WO 2022270585-A/205: Combination of antisense oligomers
GATTAAACAG
>PA566212.1 WO 2022270585-A/204: Combination of antisense oligomers
AGATTAAACA
>PA566211.1 WO 2022270585-A/203: Combination of antisense oligomers
AAGATTAAAC
>PA566210.1 WO 2022270585-A/202: Combination of antisense oligomers
AAAGATTAAA
>PA566209.1 WO 2022270585-A/201: Combination of antisense oligomers
AAAAGATTAA
>PA566208.1 WO 2022270585-A/200: Combination of antisense oligomers
GAAAAGATTA
>PA566207.1 WO 2022270585-A/199: Combination of antisense oligomers
AGAAAAGATT
>PA566206.1 WO 2022270585-A/198: Combination of antisense oligomers
GAGAAAAGAT
>PA566205.1 WO 2022270585-A/197: Combination of antisense oligomers
TGAGAAAAGA
>PA566204.1 WO 2022270585-A/196: Combination of antisense oligomers
TTGAGAAAAG
>PA566113.1 WO 2022270585-A/105: Combination of antisense oligomers
GCACACTGTT
>PA566112.1 WO 2022270585-A/104: Combination of antisense oligomers
CACACTGTTT
>PA566111.1 WO 2022270585-A/103: Combination of antisense oligomers
ACACTGTTTA
>PA566110.1 WO 2022270585-A/102: Combination of antisense oligomers
CACTGTTTAA
>PA566109.1 WO 2022270585-A/101: Combination of antisense oligomers
ACTGTTTAAT
>PA566108.1 WO 2022270585-A/100: Combination of antisense oligomers
CTGTTTAATC
>PA566107.1 WO 2022270585-A/99: Combination of antisense oligomers
TGTTTAATCT
>PA566106.1 WO 2022270585-A/98: Combination of antisense oligomers
GTTTAATCTT
>PA566105.1 WO 2022270585-A/97: Combination of antisense oligomers
TTTAATCTTT
>PA566104.1 WO 2022270585-A/96: Combination of antisense oligomers
TTAATCTTTT
>PA566103.1 WO 2022270585-A/95: Combination of antisense oligomers
TAATCTTTTC
>PA566102.1 WO 2022270585-A/94: Combination of antisense oligomers
AATCTTTTCT
>PA566101.1 WO 2022270585-A/93: Combination of antisense oligomers
ATCTTTTCTC
>PA566100.1 WO 2022270585-A/92: Combination of antisense oligomers
TCTTTTCTCA
>PA566099.1 WO 2022270585-A/91: Combination of antisense oligomers
CTTTTCTCAA
>PA564727.1 WO 2022249775-A/8: Method for editing genome
CAGGATTCGC
>PA564726.1 WO 2022249775-A/7: Method for editing genome
AGGGAGGACA
>pdb|7XP3|H Chain H, DNA complex form of ORESARA1(ANAC092) NAC Domain
NGAACGTAAC
>pdb|7OZZ|A Chain A, The crystal structure of a DNA:RNA hybrid duplex sequence CTTTTCTTTG with LNA-amide modification
CAAAGAAAAG
>pdb|7OOS|A Chain A, The crystal structure of a DNA:RNA hybrid duplex sequence CTTTTCTTTG
CAAAGAAAAG
>pdb|7OOO|D Chain D, The crystal structure of a DNA:RNA hybrid duplex sequence CTTTTCTTTG containing an LNA-Amide-LNA modification
CAAAGAAAAG
>pdb|7OOO|A Chain A, The crystal structure of a DNA:RNA hybrid duplex sequence CTTTTCTTTG containing an LNA-Amide-LNA modification
CAAAGAAAAG
>pdb|7YDW|F Chain F, Crystal structure of the MPND-DNA complex
NTTTTTTTTT
>pdb|7YDW|E Chain E, Crystal structure of the MPND-DNA complex
NAAAAAAAAA
>PA564025.1 JP 2022544004-A/46: ENGINEERED NUCLEIC ACID REGULATORY ELEMENTS AND METHODS AND USES THEREOF
TCATTCTACC
>pdb|6FUW|D Chain D, Cryo-EM structure of the human CPSF160-WDR33-CPSF30 complex bound to the PAS AAUAAA motif at 3.1 Angstrom resolution
ACAATAAAGG
>pdb|7V6V|A Chain A, trimolecular G-quadruplexes consists of a hairpin motif and two short chains
CAGGGAGGGT
>pdb|7YPA|I Chain I, Cryo-EM structure of Escherichia coli hairpin-nucleation complex of transcription termination (TTC-hairpin)
CCTGCGACGC
>pdb|7YF7|A Chain A, NMR solution structures of the DNA minidumbbell formed by two ATTTT repeats
ATTTTATTTT
>pdb|5TBC|P Chain P, PRECATALYTIC TERNARY COMPLEX OF HUMAN DNA POLYMERASE BETA WITH GAPPED DNA SUBSTRATE, INCORPORATED (-)3TC-MP AND AN ANOTHER INCOMING (-)3TC-TP NUCLEOTIDE.
GCTGATGCGC
>pdb|5TBB|P Chain P, Postcatalytic ternary complex of Human DNA Polymerase Beta with Gapped DNA substrate, incorporated (-)FTC and PPi.
GCTGATGCGC
>pdb|5TBA|P Chain P, Postcatalytic ternary complex of Human DNA Polymerase Beta with Gapped DNA substrate, incorporated (-)3TC and PPi.
GCTGATGCGC
>pdb|5TB9|P Chain P, Precatalytic ternary complex of Human DNA Polymerase Beta in closed conformation With Gapped DNA substrate incoming (-)FTC-TP and Mn2+.
GCTGATGCGC
>pdb|5TB8|P Chain P, Precatalytic ternary complex of Human DNA Polymerase Beta in closed conformation With Gapped DNA substrate incoming (-)3TC-TP and Mn2+.
GCTGATGCGC
>pdb|4NCA|F Chain F, Structure of Thermus thermophilus Argonaute bound to guide DNA 19-mer and target DNA in the presence of Mg2+
NACTACCTCG
>pdb|4NCA|D Chain D, Structure of Thermus thermophilus Argonaute bound to guide DNA 19-mer and target DNA in the presence of Mg2+
NACTACCTCG
>PA561534.1 WO 2022220141-A/253: Method for detecting mutant SARS-CoV-2
CTTTTGATGA
>PA561444.1 WO 2022220141-A/163: Method for detecting mutant SARS-CoV-2
CGCCGACGAG
>PA561434.1 WO 2022220141-A/153: Method for detecting mutant SARS-CoV-2
CCGATGAGAA
>PA559601.1 JP 2022158252-A/2: RNA fluorophore complex
GGTCGGGTCC
>PE002102.1 KR 1020220075240-A/830: MASSIVELY PARALLEL SINGLE CELL ANALYSIS
AAAAAAAAAA
>pdb|7QW7|Y Chain Y, Adenine-specific DNA methyltransferase M.BseCI complexed with AdoHcy and cognate fully methylated DNA duplex
CGATCGNTGC
>pdb|7QW7|Z Chain Z, Adenine-specific DNA methyltransferase M.BseCI complexed with AdoHcy and cognate fully methylated DNA duplex
GCATCGNTCG
>pdb|7QW6|Y Chain Y, Adenine-specific DNA methyltransferase M.BseCI complexed with AdoHcy and cognate hemimethylated DNA duplex
GCATCGNTCG
>pdb|7QW6|Z Chain Z, Adenine-specific DNA methyltransferase M.BseCI complexed with AdoHcy and cognate hemimethylated DNA duplex
CGATCGATGC
>pdb|7QW5|Y Chain Y, Adenine-specific DNA methyltransferase M.BseCI complexed with AdoHcy and cognate unmethylated DNA duplex
GCATCGATCG
>pdb|7QW5|Z Chain Z, Adenine-specific DNA methyltransferase M.BseCI complexed with AdoHcy and cognate unmethylated DNA duplex
CGATCGATGC
>OF405003.1 KR 1020220019718-A/8: MODULATING ELECTRON TRANSFER KINETICS IN E-DNA-TYPE SENSORS
ATTATTTTTT
>OF403897.1 KR 1020220024160-A/18: COMPOSITIONS AND METHODS FOR PREPARING AN ALZHEIMER'S DISEASE ANIMAL MODEL USING MICRORNA
GTCATACACG
>OF403883.1 KR 1020220024160-A/4: COMPOSITIONS AND METHODS FOR PREPARING AN ALZHEIMER'S DISEASE ANIMAL MODEL USING MICRORNA
TCATACACGG
>OF485632.1 KR 1020220070501-A/42: DIMERIZING AGENT REGULATED IMMUNORECEPTOR COMPLEXES
GCCRCCATGG
>OF485056.1 KR 1020220054727-A/18: MODULATORY POLYNUCLEOTIDES
GTGACCCAAC
>OF485055.1 KR 1020220054727-A/17: MODULATORY POLYNUCLEOTIDES
GTGACCCAAT
>OF485053.1 KR 1020220054727-A/15: MODULATORY POLYNUCLEOTIDES
GTGACCCAAG
>OF485050.1 KR 1020220054727-A/12: MODULATORY POLYNUCLEOTIDES
TATAATTTGG
>OF485049.1 KR 1020220054727-A/11: MODULATORY POLYNUCLEOTIDES
TGTGATTTGG
>OF485048.1 KR 1020220054727-A/10: MODULATORY POLYNUCLEOTIDES
TGTGACCTGG
>OF443544.1 KR 1020220024778-A/42: OLIGONUCLEOTIDE-TETHERED TRIPHOSPHATE NUCLEOTIDES USEFUL FOR LABELLING NUCLEIC ACIDS FOR PREPARING NEXT-GENERATION SEQUENCING LIBRARIES
AAAAAAAAAA
>OF441189.1 KR 1020220020378-A/52: PHARMACEUTICAL COMPOSITIONS, KITS AND METHODS FOR TREATING TUMORS
GGAGGCGGAG
>OF441186.1 KR 1020220020378-A/49: PHARMACEUTICAL COMPOSITIONS, KITS AND METHODS FOR TREATING TUMORS
GGACTGGGAG
>OF441135.1 KR 1020220033485-A/93: COMPOSITIONS AND METHODS FOR TREATING CANCER
GCCRCCATGG
>OF481955.1 KR 1020220061241-A/56: HIGHLY EFFICIENT DNA BASE EDITORS MEDIATED BY RNA-APTAMER RECRUITMENT FOR TARGETED GENOME MODIFICATION AND USES THEREOF
AATTTTTGGA
>OF481643.1 KR 1020220053048-A/145: Antisense nucleic acids
CAGTTTGCCG
>OF481534.1 KR 1020220053048-A/36: Antisense nucleic acids
TGGAGTTCCT
>OF439619.1 KR 1020220024527-A/31: SYSTEMS AND METHODS FOR IN VIVO DUAL RECOMBINASE-MEDIATED CASSETTE EXCHANGE (dRMCE) AND DISEASE MODELS THEREOF
ATTTGCATAA
>OF439615.1 KR 1020220024527-A/27: SYSTEMS AND METHODS FOR IN VIVO DUAL RECOMBINASE-MEDIATED CASSETTE EXCHANGE (dRMCE) AND DISEASE MODELS THEREOF
ACCATCTGTT
>OF439614.1 KR 1020220024527-A/26: SYSTEMS AND METHODS FOR IN VIVO DUAL RECOMBINASE-MEDIATED CASSETTE EXCHANGE (dRMCE) AND DISEASE MODELS THEREOF
GACATCTGGT
>OF439612.1 KR 1020220024527-A/24: SYSTEMS AND METHODS FOR IN VIVO DUAL RECOMBINASE-MEDIATED CASSETTE EXCHANGE (dRMCE) AND DISEASE MODELS THEREOF
CCCATTGTTC
>OF439611.1 KR 1020220024527-A/23: SYSTEMS AND METHODS FOR IN VIVO DUAL RECOMBINASE-MEDIATED CASSETTE EXCHANGE (dRMCE) AND DISEASE MODELS THEREOF
CCTTTGTTCG
>OF439609.1 KR 1020220024527-A/21: SYSTEMS AND METHODS FOR IN VIVO DUAL RECOMBINASE-MEDIATED CASSETTE EXCHANGE (dRMCE) AND DISEASE MODELS THEREOF
GATGACTCAT
>OF479757.1 KR 1020220047898-A/69: GENOME EDITED IMMUNE EFFECTOR CELLS
GCCRCCATGG
>OF390089.1 KR 1020220009992-A/7: SINGLE-CHANNEL SEQUENCING METHOD BASED ON SELF-LUMINESCENCE
TACAACTACG
>OF389897.1 KR 1020220012266-A/18: GENE THERAPY VECTORS FOR INFANTILE MALIGNANT OSTEOPETROSIS
GACACCATGG
>OF388379.1 KR 1020220031554-A/83: CD33 TARGETED IMMUNOTHERAPIES
GCCRCCATGG
>OF388232.1 KR 1020220007104-A/15: CONVERGENT LIQUID PHASE SYNTHESES OF OLIGONUCLEOTIDES
ACAGATATTT
>OF388230.1 KR 1020220007104-A/13: CONVERGENT LIQUID PHASE SYNTHESES OF OLIGONUCLEOTIDES
TTACCACCCT
>OF388229.1 KR 1020220007104-A/12: CONVERGENT LIQUID PHASE SYNTHESES OF OLIGONUCLEOTIDES
GTTTTTGCAA
>OF388227.1 KR 1020220007104-A/10: CONVERGENT LIQUID PHASE SYNTHESES OF OLIGONUCLEOTIDES
GTTTTTTGTT
>OF387648.1 KR 1020220030933-A/45: ENGINEERED T CELLS
GCCRCCATGG
>OF387647.1 KR 1020220031549-A/51: CLL-1 TARGETED IMMUNOTHERAPIES
GCCRCCATGG
>OF471753.1 KR 1020220051401-A/236: GENETICALLY ENGINEERED T CELLS HAVING IMPROVED PERSISTENCE IN CULTURE
AATGGGGATG
>OF471752.1 KR 1020220051401-A/235: GENETICALLY ENGINEERED T CELLS HAVING IMPROVED PERSISTENCE IN CULTURE
CTGCACAGTC
>OF385867.1 KR 1020220010722-A/65: IMMUNE CELL RECEPTORS COMPRSING CD4 BINDING MOIETIES
CCNNNNNNGG
>OF469777.1 KR 1020220049619-A/556: SYSTEM FOR REGULATING GENE EXPRESSION
TGGGGAGGTG
>OF469632.1 KR 1020220049619-A/411: SYSTEM FOR REGULATING GENE EXPRESSION
GCGTTCTTGT
>OF469463.1 KR 1020220049619-A/242: SYSTEM FOR REGULATING GENE EXPRESSION
ACTTTGTCAC
>OF469461.1 KR 1020220049619-A/240: SYSTEM FOR REGULATING GENE EXPRESSION
CGTGTCGGTG
>OF469447.1 KR 1020220049619-A/226: SYSTEM FOR REGULATING GENE EXPRESSION
CGTGTGGGTG
>OF469438.1 KR 1020220049619-A/217: SYSTEM FOR REGULATING GENE EXPRESSION
CTAATAAAGT
>OF469387.1 KR 1020220049619-A/166: SYSTEM FOR REGULATING GENE EXPRESSION
CGTGTCGGGT
>OF469386.1 KR 1020220049619-A/165: SYSTEM FOR REGULATING GENE EXPRESSION
ACTTCACACG
>OF469361.1 KR 1020220049619-A/140: SYSTEM FOR REGULATING GENE EXPRESSION
CCTGCCGGGT
>OF469357.1 KR 1020220049619-A/136: SYSTEM FOR REGULATING GENE EXPRESSION
CTTTCGCAGG
>OF469356.1 KR 1020220049619-A/135: SYSTEM FOR REGULATING GENE EXPRESSION
CCTGCAGGGT
>OF469353.1 KR 1020220049619-A/132: SYSTEM FOR REGULATING GENE EXPRESSION
CCTGCAGGGT
>OF469348.1 KR 1020220049619-A/127: SYSTEM FOR REGULATING GENE EXPRESSION
TACCTAATAA
>OF469345.1 KR 1020220049619-A/124: SYSTEM FOR REGULATING GENE EXPRESSION
CCTAATAAAG
>OF469344.1 KR 1020220049619-A/123: SYSTEM FOR REGULATING GENE EXPRESSION
TCCTGCCGGG
>OF469336.1 KR 1020220049619-A/115: SYSTEM FOR REGULATING GENE EXPRESSION
ACCTAATAAA
>OF469334.1 KR 1020220049619-A/113: SYSTEM FOR REGULATING GENE EXPRESSION
CCTGCGGGTG
>OF469325.1 KR 1020220049619-A/104: SYSTEM FOR REGULATING GENE EXPRESSION
TTGGACAACA
>OF467289.1 KR 1020220064973-A/2: COMPOSITIONS AND METHODS FOR DETECTING RARE SEQUENCE VARIANTS
CAGGTACCAT
>OF467288.1 KR 1020220064973-A/1: COMPOSITIONS AND METHODS FOR DETECTING RARE SEQUENCE VARIANTS
CAGCTACCAT
>OF382216.1 KR 1020220009966-A/65: ENGINEERED IMMUNE CELLS COMPRSING A RECOGNITION MOLECULE
CCNNNNNNGG
>OF380337.1 KR 1020220002910-A/18: TRIPLE HELIX TERMINATOR FOR EFFICIENT RNA TRANS-SPLICING
TTTTTCTTTT
>OF379464.1 KR 1020220002882-A/3: COMPOSITIONS AND METHODS FOR TREATING HUNTINGTON'S DISEASE
GAGGTAAGTA
>OF379463.1 KR 1020220002882-A/2: COMPOSITIONS AND METHODS FOR TREATING HUNTINGTON'S DISEASE
TACNNACCTG
>OF379462.1 KR 1020220002882-A/1: COMPOSITIONS AND METHODS FOR TREATING HUNTINGTON'S DISEASE
CAGGTAAGTA
>OF379438.1 KR 1020220010471-A/38: ELECTROCHEMILUMINESCENT LABELED PROBES FOR USE IN IMMUNOASSAY METHODS, METHODS USING SUCH AND KITS COMPRISING SAME
AAAAAAAAAA
>OF379428.1 KR 1020220010471-A/28: ELECTROCHEMILUMINESCENT LABELED PROBES FOR USE IN IMMUNOASSAY METHODS, METHODS USING SUCH AND KITS COMPRISING SAME
AAGCGTCTTA
>OF463884.1 KR 1020220038549-A/143: MACROMOLECULE ANALYSIS EMPLOYING NUCLEIC ACID ENCODING
TTTTTTTTTT
>OF378737.1 KR 1020220047206-A/11: ATTACHING NUCLEOTIDES TO A POLYNUCLEOTIDE WITH A POLYMERASE
TTTTTTTTTT
>OF378439.1 KR 1020220003495-A/100: Composition for inhibiting CTGF expression
AACTTGAACT
>OF376153.1 KR 1020220059418-A/16: Microparticle probe for nucleic acid separation and detection for multiplexed diagnosis
TTATTATTTT
>OF459647.1 KR 1020220047319-A/206: RNA COMBINATIONS AND COMPOSITIONS WITH DECREASED IMMUNOSTIMULATORY PROPERTIES
GGNCNACNNN
>OF374824.1 KR 1020220031527-A/13: Method for detecting noxious substance of food
ATACGGGAGC
>OF374823.1 KR 1020220031527-A/12: Method for detecting noxious substance of food
GTCCAAGAGC
>OF374822.1 KR 1020220031527-A/11: Method for detecting noxious substance of food
GCAATACCTC
>OF374821.1 KR 1020220031527-A/10: Method for detecting noxious substance of food
GTGTGACGGA
>OF374816.1 KR 1020220031527-A/5: Method for detecting noxious substance of food
GCTCTTGGAC
>OF374814.1 KR 1020220031527-A/3: Method for detecting noxious substance of food
GTCCAAGAGC
>OF374358.1 KR 1020220040983-A/16: Prime editing-based gene editing composition with improved editing efficiency and use thereof
ATGGAGATGT
>OF372816.1 KR 1020220047502-A/550: An engineered guide RNA for the optimized CRISPR/Cas12f1(Cas14a1) system and use thereof
TTTTATTTTT
>OF372691.1 KR 1020220047502-A/403: An engineered guide RNA for the optimized CRISPR/Cas12f1(Cas14a1) system and use thereof
TATTTGTTTC
>OF372686.1 KR 1020220047502-A/398: An engineered guide RNA for the optimized CRISPR/Cas12f1(Cas14a1) system and use thereof
TTATGTTTTT
>OF372685.1 KR 1020220047502-A/397: An engineered guide RNA for the optimized CRISPR/Cas12f1(Cas14a1) system and use thereof
TTTCTATTTT
>OF372682.1 KR 1020220047502-A/394: An engineered guide RNA for the optimized CRISPR/Cas12f1(Cas14a1) system and use thereof
TGTGTGTTTT
>OF372680.1 KR 1020220047502-A/392: An engineered guide RNA for the optimized CRISPR/Cas12f1(Cas14a1) system and use thereof
TTTTTTTTTT
>OF372548.1 KR 1020220047502-A/260: An engineered guide RNA for the optimized CRISPR/Cas12f1(Cas14a1) system and use thereof
ATAAAGGTGA
>OF372537.1 KR 1020220047502-A/249: An engineered guide RNA for the optimized CRISPR/Cas12f1(Cas14a1) system and use thereof
AAGTGGAGAA
>OF372535.1 KR 1020220047502-A/247: An engineered guide RNA for the optimized CRISPR/Cas12f1(Cas14a1) system and use thereof
CCGTTAGGTG
>OF457037.1 KR 1020220077907-A/12: LIBRARY CREATION METHOD AND APPLICATION
CAGATCCATC
>OF457036.1 KR 1020220077907-A/11: LIBRARY CREATION METHOD AND APPLICATION
TTAGTCGGAC
>OF457035.1 KR 1020220077907-A/10: LIBRARY CREATION METHOD AND APPLICATION
AGGCAATTGC
>OF457034.1 KR 1020220077907-A/9: LIBRARY CREATION METHOD AND APPLICATION
TCTATTCGTC
>OF457033.1 KR 1020220077907-A/8: LIBRARY CREATION METHOD AND APPLICATION
TCTGGATGAC
>OF457032.1 KR 1020220077907-A/7: LIBRARY CREATION METHOD AND APPLICATION
TCTAGAGGTC
>OF457031.1 KR 1020220077907-A/6: LIBRARY CREATION METHOD AND APPLICATION
TTGGAGTGTC
>OF457030.1 KR 1020220077907-A/5: LIBRARY CREATION METHOD AND APPLICATION
TCTAACGGAC
>OF457029.1 KR 1020220077907-A/4: LIBRARY CREATION METHOD AND APPLICATION
TAGGTGGTTC
>OF457028.1 KR 1020220077907-A/3: LIBRARY CREATION METHOD AND APPLICATION
TCCTCGAATC
>OF456731.1 KR 1020220038755-A/41: HANTAVIRUS ANTIGENIC COMPOSITION
GCCACCATGG
>OF456486.1 KR 1020220028183-A/55: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
CTAATAAGCT
>OF456485.1 KR 1020220028183-A/54: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
TCTAATAAGC
>OF456477.1 KR 1020220028183-A/46: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
TAATAAGCTA
>OF456472.1 KR 1020220028183-A/41: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
CTGATAAGCT
>OF456471.1 KR 1020220028183-A/40: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
TCTGATAAGC
>OF456455.1 KR 1020220028183-A/24: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
TGATAAGCTA
>OF370847.1 KR 1020220085965-A/2: Novel white Hypsizygus marmoreus BW80(KACC93351P) strain that can be co-cultivated with brown beech mushroom
GCCACCTCCT
>OF370846.1 KR 1020220085965-A/1: Novel white Hypsizygus marmoreus BW80(KACC93351P) strain that can be co-cultivated with brown beech mushroom
CTGACACGGA
>OF368671.1 KR 1020220069342-A/1: Lentinula edodes BL48(KACC93342P) strain with short cultivation period adapted to bottle cultivation
CAGGCCCTTC
>OF367880.1 KR 1020220047493-A/27: An engineered crRNA for CRISPR/Cas12a system
TTTTATTTTT
>OF367873.1 KR 1020220047493-A/20: An engineered crRNA for CRISPR/Cas12a system
TTTTTTTTTT
>OF367871.1 KR 1020220047493-A/18: An engineered crRNA for CRISPR/Cas12a system
TTTTATTTTC
>OF367868.1 KR 1020220047493-A/15: An engineered crRNA for CRISPR/Cas12a system
TTGTTATTTC
>OF367865.1 KR 1020220047493-A/12: An engineered crRNA for CRISPR/Cas12a system
TTTTACTTTT
>OF367862.1 KR 1020220047493-A/9: An engineered crRNA for CRISPR/Cas12a system
TTTATTGGTT
>OF367861.1 KR 1020220047493-A/8: An engineered crRNA for CRISPR/Cas12a system
TTTTATTTAA
>OF367860.1 KR 1020220047493-A/7: An engineered crRNA for CRISPR/Cas12a system
TTTTTTTTTT
>OF367859.1 KR 1020220047493-A/6: An engineered crRNA for CRISPR/Cas12a system
TTTTTTTTTT
>OF367826.1 KR 1020220062841-A/3: Method and Kit for Identifying F18 encoding enterotoxigenic and shigatoxin-producing Escherichia coli in Pigs using PNA probe
CACAGGGGCA
>OF492624.1 KR 1020220082047-A/35: VECTOR FOR CANCER TREATMENT
ACCCAGCTTT
>OF408660.1 KR 1020220005641-A/13: MUCOADHESIVE MICROORGANISM
GGAGGAAAAA
>OF490871.1 KR 1020220070324-A/544: OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF
GTGAGTGAGG
>OF490870.1 KR 1020220070324-A/543: OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF
TGGCGAGTGG
>OF405952.1 KR 1020220035338-A/185: ENHANCING PRODUCTION OF LENTIVIRAL VECTORS
ATAATTTGTG
>OF362979.1 KR 1020220015211-A/2: antimicrobial composition against Floroquinolone antibiotic-resistant E. coli comprising novel peptide nucleic acid
GCGATATCGC
>pdb|8EDJ|R Chain R, Crystal structure of rA3G-ssRNA-GA
TTTTGATTTT
>pdb|7UU4|R Chain R, Crystal structure of APOBEC3G complex with ssRNA
TTTTAATTTT
>pdb|7NWI|K Chain K, Mammalian pre-termination 80S ribosome with Empty-A site bound by Blasticidin S
NAAGTTTAGG
>PA557744.1 WO 2022191172-A/4: LINKER AND CARRIER FOR NUCLEIC ACID SOLID-PHASE SYNTHESIS
TTTTTTTTTG
>PA557743.1 WO 2022191172-A/3: LINKER AND CARRIER FOR NUCLEIC ACID SOLID-PHASE SYNTHESIS
TTTTTTTTTC
>PA557742.1 WO 2022191172-A/2: LINKER AND CARRIER FOR NUCLEIC ACID SOLID-PHASE SYNTHESIS
TTTTTTTTTA
>PA557741.1 WO 2022191172-A/1: LINKER AND CARRIER FOR NUCLEIC ACID SOLID-PHASE SYNTHESIS
TTTTTTTTTT
>PA555931.1 WO 2022181550-A/6: Anti-SARS-CoV-2 antibody
GGGSHHHHHH
>PA555664.1 WO 2022185664-A/24: translation enhancer
GGGCCAAAGA
>PA555644.1 WO 2022185664-A/4: translation enhancer
GGGCCAAAGA
>PA555516.1 JP 2022134257-A/24: translation enhancer
GGGCCAAAGA
>PA555496.1 JP 2022134257-A/4: translation enhancer
GGGCCAAAGA
>pdb|7U3Y|Y Chain Y, [L233] Self-assembling tensegrity triangle with two turns, three turns and three turns of DNA per axis by linker addition with P1 symmetry
CTTAGCATAG
>pdb|7U3Y|X Chain X, [L233] Self-assembling tensegrity triangle with two turns, three turns and three turns of DNA per axis by linker addition with P1 symmetry
NTCTATGCTA
>pdb|7U3Y|V Chain V, [L233] Self-assembling tensegrity triangle with two turns, three turns and three turns of DNA per axis by linker addition with P1 symmetry
TGCGCTAGCG
>pdb|7U3Y|U Chain U, [L233] Self-assembling tensegrity triangle with two turns, three turns and three turns of DNA per axis by linker addition with P1 symmetry
NCCGCTAGCG
>pdb|7U3U|X Chain X, [L223] Self-assembling tensegrity triangle with two turns, two turns and three turns of DNA per axis by linker addition with P1 symmetry
NTTAGCAGAG
>pdb|7U3U|Y Chain Y, [L223] Self-assembling tensegrity triangle with two turns, two turns and three turns of DNA per axis by linker addition with P1 symmetry
GACTCTGCTA
>pdb|7U3R|X Chain X, [2T7+10] Self-assembling tensegrity triangle with two turns of DNA and the sticky end attachment of a one-turn linker per axis, with R3 symmetry
NTACTCAGCA
>pdb|7U3R|Y Chain Y, [2T7+10] Self-assembling tensegrity triangle with two turns of DNA and the sticky end attachment of a one-turn linker per axis, with R3 symmetry
GATGCTGAGT
>pdb|1NH3|B Chain B, Human Topoisomerase I Ara-C Complex
AAAAAGACNN
>pdb|1I6J|C Chain C, CRYSTAL STRUCTURE OF A PSEUDO-16-MER DNA WITH STACKED GUANINES AND TWO G-A MISPAIRS COMPLEXED WITH THE N-TERMINAL FRAGMENT OF MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE
ACGGGACGAC
>pdb|5GXI|B Chain B, Structure of the Gemin5 WD40 domain in complex with AAUUUUUGAG
AATTTTTGAG
>pdb|7W0V|B Chain B, C4'-SCF3-DT modifeid DNA-DNA duplex
GCTATAATGG
>pdb|7W0V|A Chain A, C4'-SCF3-DT modifeid DNA-DNA duplex
CCATNATAGC
>pdb|7QA9|B Chain B, 10bp DNA/DNA duplex
GCTATAATGG
>pdb|7QA9|A Chain A, 10bp DNA/DNA duplex
CCATTATAGC
>pdb|7SVB|D Chain D, APE1 exonuclease substrate complex with 8oxoG opposite C
GCTGATGCGN
>pdb|7SUV|D Chain D, APE1 exonuclease substrate complex with 8oxoG opposite A
GCTGATGCGN
>pdb|6WVJ|N Chain N, Cryo-EM structure of Bacillus subtilis RNA Polymerase elongation complex
NCGCCCGACA
>pdb|4WT8|B2 Chain B2, Crystal Structure of bactobolin A bound to 70S ribosome-tRNA complex
NAAATGTTCA
>pdb|4PJO|y Chain y, Minimal U1 snRNP
AGGTAAGTCC
>pdb|4PJO|x Chain x, Minimal U1 snRNP
AGGTAAGTCC
>pdb|4V4I|1 Chain 1, Crystal Structure of a 70S Ribosome-tRNA Complex Reveals Functional Interactions and Rearrangements.
ATGTTCTAAA
>pdb|6WNW|1 Chain 1, Active 70S ribosome without free 5S rRNA and bound with A- and P- tRNA
NAAATGTTCA
>pdb|5IQR|7 Chain 7, Structure of RelA bound to the 70S ribosome
NAAATGTTCT
>pdb|4PJO|Y Chain Y, Minimal U1 snRNP
AGGTAAGTCC
>pdb|4PJO|X Chain X, Minimal U1 snRNP
AGGTAAGTCC
>PA553265.1 WO 2022158497-A/51: Antibodies against SARS-CoV-2 spike protein
CGTGCAAACN
>PA553259.1 WO 2022158497-A/45: Antibodies against SARS-CoV-2 spike protein
GACACATCCN
>PA553253.1 WO 2022158497-A/39: Antibodies against SARS-CoV-2 spike protein
GCTGCATCCN
>PA553247.1 WO 2022158497-A/33: Antibodies against SARS-CoV-2 spike protein
CTCACATCCN
>PA553241.1 WO 2022158497-A/27: Antibodies against SARS-CoV-2 spike protein
GCTGCATCCN
>PA551479.1 JP 2022101241-A/24: Nucleic acid amplification method, primer set, probe, and kit for nucleic acid amplification
CAACATCAGT
>PA551474.1 JP 2022101241-A/19: Nucleic acid amplification method, primer set, probe, and kit for nucleic acid amplification
CTTATCAGAC
>pdb|8DMB|Y Chain Y, Structure of Desulfovirgula thermocuniculi IsrB (DtIsrB) in complex with omega RNA and target DNA
TTGAGCTGAT
>pdb|6WG6|N Chain N, Crystal structure of human SMC1-SMC3 hinge domain heterodimer in north-open conformation
NTTTTTTTTT
>pdb|6WG6|M Chain M, Crystal structure of human SMC1-SMC3 hinge domain heterodimer in north-open conformation
NTTTTTTTTT
>pdb|7YVX|A Chain A, Left-handed DNA duplex containing consecutive G-G base pairs
CGNGGGCGCG
>pdb|7XLW|L Chain L, Crystal structure of a NIR-emitting DNA-stabilized Ag16 nanocluster (G7I/G9I mutant)
CACCTANCNA
>pdb|7XLW|K Chain K, Crystal structure of a NIR-emitting DNA-stabilized Ag16 nanocluster (G7I/G9I mutant)
CACCTANCNA
>pdb|7XLW|J Chain J, Crystal structure of a NIR-emitting DNA-stabilized Ag16 nanocluster (G7I/G9I mutant)
CACCTANCNA
>pdb|7XLW|I Chain I, Crystal structure of a NIR-emitting DNA-stabilized Ag16 nanocluster (G7I/G9I mutant)
CACCTANCNA
>pdb|7XLW|H Chain H, Crystal structure of a NIR-emitting DNA-stabilized Ag16 nanocluster (G7I/G9I mutant)
CACCTANCNA
>pdb|7XLW|G Chain G, Crystal structure of a NIR-emitting DNA-stabilized Ag16 nanocluster (G7I/G9I mutant)
CACCTANCNA
>pdb|7XLW|F Chain F, Crystal structure of a NIR-emitting DNA-stabilized Ag16 nanocluster (G7I/G9I mutant)
CACCTANCNA
>pdb|7XLW|E Chain E, Crystal structure of a NIR-emitting DNA-stabilized Ag16 nanocluster (G7I/G9I mutant)
CACCTANCNA
>pdb|7XLW|D Chain D, Crystal structure of a NIR-emitting DNA-stabilized Ag16 nanocluster (G7I/G9I mutant)
CACCTANCNA
>pdb|7XLW|C Chain C, Crystal structure of a NIR-emitting DNA-stabilized Ag16 nanocluster (G7I/G9I mutant)
CACCTANCNA
>pdb|7XLW|B Chain B, Crystal structure of a NIR-emitting DNA-stabilized Ag16 nanocluster (G7I/G9I mutant)
CACCTANCNA
>pdb|7XLW|A Chain A, Crystal structure of a NIR-emitting DNA-stabilized Ag16 nanocluster (G7I/G9I mutant)
CACCTANCNA
>pdb|7XLV|B Chain B, Crystal structure of a NIR-emitting DNA-stabilized Ag16 nanocluster (G7I mutant)
CACCTANCGA
>pdb|7XLV|A Chain A, Crystal structure of a NIR-emitting DNA-stabilized Ag16 nanocluster (G7I mutant)
CACCTANCGA
>PA550954.1 WO 2022138899-A/24: Nucleic acid amplification method, primer set, probe, and kit for nucleic acid amplification method
CAACATCAGT
>PA550949.1 WO 2022138899-A/19: Nucleic acid amplification method, primer set, probe, and kit for nucleic acid amplification method
CTTATCAGAC
>PA548215.1 JP 2022089532-A/2: Nucleic acid construct set, kit, detection method and mothod for predicting drug effect
TTATGCGGCG
>PA547955.1 JP 2022086783-A/3: PROMOTER FOR FILAMENTOUS FUNGI AND USE THEREOF
CGGNNATTTA
>PA547944.1 JP 2022085159-A/6: Detection method of a target nucleotide and a kit
TTTTTTTTTT
>PA547852.1 JP 2022523148-A/76: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
TGGGTACCTG
>PA547851.1 JP 2022523148-A/75: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GGGGTAAGTG
>PA547849.1 JP 2022523148-A/73: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAAGGC
>PA547848.1 JP 2022523148-A/72: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTATGAG
>PA547847.1 JP 2022523148-A/71: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
TGGGTGGGTG
>PA547846.1 JP 2022523148-A/70: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
TGGGTGGGGG
>PA547845.1 JP 2022523148-A/69: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
TGGGTACCTG
>PA547843.1 JP 2022523148-A/67: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GTTTTGGTGA
>PA547841.1 JP 2022523148-A/65: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GTGGTAAGTG
>PA547840.1 JP 2022523148-A/64: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GGGGTTGGGA
>PA547839.1 JP 2022523148-A/63: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GGGGTGAGTG
>PA547838.1 JP 2022523148-A/62: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GGGGTAAGTG
>PA547837.1 JP 2022523148-A/61: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GCGGTGAGCT
>PA547836.1 JP 2022523148-A/60: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GCGGTGAGCA
>PA547835.1 JP 2022523148-A/59: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GCGGTAATCA
>PA547834.1 JP 2022523148-A/58: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTGCGGG
>PA547833.1 JP 2022523148-A/57: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTCTGGT
>PA547832.1 JP 2022523148-A/56: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTAATGT
>PA547831.1 JP 2022523148-A/55: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTAATAT
>PA547830.1 JP 2022523148-A/54: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTAATAC
>PA547829.1 JP 2022523148-A/53: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTAAGCG
>PA547828.1 JP 2022523148-A/52: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTAAGAG
>PA547824.1 JP 2022523148-A/48: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CTGGTGAGTC
>PA547822.1 JP 2022523148-A/46: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CATGGAAGAC
>PA547821.1 JP 2022523148-A/45: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTTTAGT
>PA547820.1 JP 2022523148-A/44: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTGGGTG
>PA547818.1 JP 2022523148-A/42: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTGAGGG
>PA547817.1 JP 2022523148-A/41: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTCTGGT
>PA547816.1 JP 2022523148-A/40: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTCTGGA
>PA547815.1 JP 2022523148-A/39: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTCAGTG
>PA547812.1 JP 2022523148-A/36: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAGCAA
>PA547811.1 JP 2022523148-A/35: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTACAGT
>PA547810.1 JP 2022523148-A/34: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAATGT
>PA547809.1 JP 2022523148-A/33: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAATGC
>PA547808.1 JP 2022523148-A/32: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAAGAC
>PA547806.1 JP 2022523148-A/30: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAAGGC
>PA547805.1 JP 2022523148-A/29: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAAGTAAGTA
>PA547804.1 JP 2022523148-A/28: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAAGGTACCT
>PA547803.1 JP 2022523148-A/27: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
ATCGGTAAAA
>PA547801.1 JP 2022523148-A/25: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AGGGTAATGA
>PA547800.1 JP 2022523148-A/24: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
ACTGTGAGTG
>PA547799.1 JP 2022523148-A/23: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
ACGGTGAGTG
>PA547798.1 JP 2022523148-A/22: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
ACCGTGAGTT
>PA547797.1 JP 2022523148-A/21: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTTAGTG
>PA547796.1 JP 2022523148-A/20: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTGGGCC
>PA547795.1 JP 2022523148-A/19: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTGAGTC
>PA547794.1 JP 2022523148-A/18: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTGAGAT
>PA547792.1 JP 2022523148-A/16: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTCTGGG
>PA547791.1 JP 2022523148-A/15: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTATATT
>PA547790.1 JP 2022523148-A/14: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAGACC
>PA547788.1 JP 2022523148-A/12: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAATGT
>PA547787.1 JP 2022523148-A/11: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAATAA
>PA547786.1 JP 2022523148-A/10: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAAGCG
>PA547785.1 JP 2022523148-A/9: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAAGCC
>PA547783.1 JP 2022523148-A/7: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTATGAG
>PA547782.1 JP 2022523148-A/6: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGCAGGGA
>PA547781.1 JP 2022523148-A/5: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGCAAGGG
>PA547780.1 JP 2022523148-A/4: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AACATGAGGA
>PA547779.1 JP 2022523148-A/3: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAAGTGAGTT
>PA547778.1 JP 2022523148-A/2: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAAGTGAGTG
>PA547777.1 JP 2022523148-A/1: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAAGTAAGTA
>PA547110.1 WO 2022102791-A/14: Novel linker and method for detecting antigen by using thereof
GATGATGATG
>PA545403.1 JP 2022073404-A/14: Methods to identify Anisakis species
AGTCTGCTCG
>PA545402.1 JP 2022073404-A/13: Methods to identify Anisakis species
CTGCCTTAAG
>PA545401.1 JP 2022073404-A/12: Methods to identify Anisakis species
AGGCAGAGTC
>PA545400.1 JP 2022073404-A/11: Methods to identify Anisakis species
CTGCAGCAGC
>PA545395.1 JP 2022073404-A/6: Methods to identify Anisakis species
AGTCTGCTCA
>PA545394.1 JP 2022073404-A/5: Methods to identify Anisakis species
CTGCCTTAAA
>PA545393.1 JP 2022073404-A/4: Methods to identify Anisakis species
AGGCAGAGTT
>PA545392.1 JP 2022073404-A/3: Methods to identify Anisakis species
CTGCAGCAGT
>pdb|7S68|N Chain N, Structure of human PARP1 domains (Zn1, Zn3, WGR and HD) bound to a DNA double strand break.
GCCTGCAGGC
>pdb|7S68|M Chain M, Structure of human PARP1 domains (Zn1, Zn3, WGR and HD) bound to a DNA double strand break.
GCCTGCAGGC
>pdb|4QIO|A Chain A, Lambda-[Ru(TAP)2(dppz)]2+ bound to d(TCGGCGCCIA) at high resolution
TCGGCGCCNA
>pdb|8DQX|K Chain K, Open state of RFC:PCNA bound to a 3' ss/dsDNA junction
NTTGCCCGGA
>pdb|8DQX|J Chain J, Open state of RFC:PCNA bound to a 3' ss/dsDNA junction
NCCGAGCGAA
>pdb|7R6V|K Chain K, Human EXOG complexed with dRP-containing DNA
NTGACGTGCG
>pdb|7R6V|J Chain J, Human EXOG complexed with dRP-containing DNA
NTGACGTGCG
>pdb|7R6V|H Chain H, Human EXOG complexed with dRP-containing DNA
NTGACGTGCG
>pdb|7R6V|F Chain F, Human EXOG complexed with dRP-containing DNA
CTGACGTGCG
>pdb|7R6T|M Chain M, Human EXOG complexed with dRP-containing DNA
NCTGACGTGC
>pdb|7R6T|E Chain E, Human EXOG complexed with dRP-containing DNA
NCTGACGTGC
>pdb|7R6T|F Chain F, Human EXOG complexed with dRP-containing DNA
NCTGACGTGC
>pdb|7PDV|F Chain F, Crystal structure of RBM5 RRM1-zinc finger in complex with RNA
NGGCTCTTCT
>pdb|4OU7|S Chain S, Crystal structure of DnaT84-153-dT10 ssDNA complex reveals a novel single-stranded DNA binding mode
NTTTTTTTTT
>pdb|4OU6|L Chain L, Crystal structure of DnaT84-153-dT10 ssDNA complex form 1
NTTTTTTTTT
>pdb|2RT8|B Chain B, Structure of metallo-dna in solution
GGACTTCGCG
>pdb|2RT8|A Chain A, Structure of metallo-dna in solution
CGCGTTGTCC
>pdb|3VYY|G Chain G, Structural insights into RISC assembly facilitated by dsRNA binding domains of human RNA helicase A (DHX9)
GCGCGCGCGC
>pdb|3VYY|F Chain F, Structural insights into RISC assembly facilitated by dsRNA binding domains of human RNA helicase A (DHX9)
GCGCGCGCGC
>pdb|3VYY|E Chain E, Structural insights into RISC assembly facilitated by dsRNA binding domains of human RNA helicase A (DHX9)
GCGCGCGCGC
>pdb|3VYY|D Chain D, Structural insights into RISC assembly facilitated by dsRNA binding domains of human RNA helicase A (DHX9)
GCGCGCGCGC
>pdb|3VYY|C Chain C, Structural insights into RISC assembly facilitated by dsRNA binding domains of human RNA helicase A (DHX9)
GCGCGCGCGC
>pdb|3VYX|C Chain C, Structural insights into RISC assembly facilitated by dsRNA binding domains of human RNA helicase (DHX9)
NCGCGCGCGC
>pdb|3VYX|B Chain B, Structural insights into RISC assembly facilitated by dsRNA binding domains of human RNA helicase (DHX9)
NCGCGCGCGC
>pdb|7S9Q|P Chain P, Ternary complex of DNA Polymerase Beta with Template Fapy-dG and an incoming dATP analog
GCTGATGCGA
>pdb|7S9P|P Chain P, Ternary complex of DNA Polymerase Beta with Template Fapy-dG and an incoming dCTP analog
GCTGATGCGA
>pdb|7S9O|P Chain P, Binary complex of DNA Polymerase Beta with Ring open Intermediate Fapy-dG in the template position
GCTGATGCGA
>pdb|7S9N|P Chain P, Binary complex of DNA Polymerase Beta with Fapy-dG in the template position
GCTGATGCGA
>pdb|7S9M|P Chain P, Crystal Structure of DNA Polymerase Beta with Ring open intermediate Fapy-dG base-paired with a dA
GCTAATGCGC
>pdb|7S9L|P Chain P, Crystal Structure of DNA Polymerase Beta with Ring open intermediate Fapy-dG base-paired with a dC
GCTCATGCGC
>pdb|7S9K|P Chain P, Crystal Structure of DNA Polymerase Beta with Fapy-dG base-paired with a dA
GCTAATGCGC
>pdb|7S9J|P Chain P, Crystal Structure of DNA Polymerase Beta with Fapy-dG base-paired with a dC
GCTCATGCGC
>pdb|7NRP|B Chain B, The crystal structure of a DNA:RNA hybrid duplex sequence CTTTTCTTTG
CTTTTCTTTG
>pdb|7NRP|A Chain A, The crystal structure of a DNA:RNA hybrid duplex sequence CTTTTCTTTG
CAAAGAAAAG
>PA544625.1 JP 2022519312-A/76: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
TGGGTACCTG
>PA544624.1 JP 2022519312-A/75: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GGGGTAAGTG
>PA544622.1 JP 2022519312-A/73: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAAGGC
>PA544621.1 JP 2022519312-A/72: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTATGAG
>PA544620.1 JP 2022519312-A/71: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
TGGGTGGGTG
>PA544619.1 JP 2022519312-A/70: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
TGGGTGGGGG
>PA544618.1 JP 2022519312-A/69: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
TGGGTACCTG
>PA544616.1 JP 2022519312-A/67: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GTTTTGGTGA
>PA544614.1 JP 2022519312-A/65: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GTGGTAAGTG
>PA544613.1 JP 2022519312-A/64: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GGGGTTGGGA
>PA544612.1 JP 2022519312-A/63: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GGGGTGAGTG
>PA544611.1 JP 2022519312-A/62: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GGGGTAAGTG
>PA544610.1 JP 2022519312-A/61: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GCGGTGAGCT
>PA544609.1 JP 2022519312-A/60: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GCGGTGAGCA
>PA544608.1 JP 2022519312-A/59: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GCGGTAATCA
>PA544607.1 JP 2022519312-A/58: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTGCGGG
>PA544606.1 JP 2022519312-A/57: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTCTGGT
>PA544605.1 JP 2022519312-A/56: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTAATGT
>PA544604.1 JP 2022519312-A/55: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTAATAT
>PA544603.1 JP 2022519312-A/54: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTAATAC
>PA544602.1 JP 2022519312-A/53: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTAAGCG
>PA544601.1 JP 2022519312-A/52: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTAAGAG
>PA544597.1 JP 2022519312-A/48: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CTGGTGAGTC
>PA544595.1 JP 2022519312-A/46: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CATGGAAGAC
>PA544594.1 JP 2022519312-A/45: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTTTAGT
>PA544593.1 JP 2022519312-A/44: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTGGGTG
>PA544591.1 JP 2022519312-A/42: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTGAGGG
>PA544590.1 JP 2022519312-A/41: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTCTGGT
>PA544589.1 JP 2022519312-A/40: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTCTGGA
>PA544588.1 JP 2022519312-A/39: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTCAGTG
>PA544585.1 JP 2022519312-A/36: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAGCAA
>PA544584.1 JP 2022519312-A/35: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTACAGT
>PA544583.1 JP 2022519312-A/34: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAATGT
>PA544582.1 JP 2022519312-A/33: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAATGC
>PA544581.1 JP 2022519312-A/32: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAAGAC
>PA544579.1 JP 2022519312-A/30: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAAGGC
>PA544578.1 JP 2022519312-A/29: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAAGTAAGTA
>PA544577.1 JP 2022519312-A/28: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAAGGTACCT
>PA544576.1 JP 2022519312-A/27: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
ATCGGTAAAA
>PA544574.1 JP 2022519312-A/25: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AGGGTAATGA
>PA544573.1 JP 2022519312-A/24: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
ACTGTGAGTG
>PA544572.1 JP 2022519312-A/23: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
ACGGTGAGTG
>PA544571.1 JP 2022519312-A/22: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
ACCGTGAGTT
>PA544570.1 JP 2022519312-A/21: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTTAGTG
>PA544569.1 JP 2022519312-A/20: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTGGGCC
>PA544568.1 JP 2022519312-A/19: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTGAGTC
>PA544567.1 JP 2022519312-A/18: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTGAGAT
>PA544565.1 JP 2022519312-A/16: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTCTGGG
>PA544564.1 JP 2022519312-A/15: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTATATT
>PA544563.1 JP 2022519312-A/14: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAGACC
>PA544561.1 JP 2022519312-A/12: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAATGT
>PA544560.1 JP 2022519312-A/11: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAATAA
>PA544559.1 JP 2022519312-A/10: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAAGCG
>PA544558.1 JP 2022519312-A/9: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAAGCC
>PA544556.1 JP 2022519312-A/7: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTATGAG
>PA544555.1 JP 2022519312-A/6: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGCAGGGA
>PA544554.1 JP 2022519312-A/5: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGCAAGGG
>PA544553.1 JP 2022519312-A/4: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AACATGAGGA
>PA544552.1 JP 2022519312-A/3: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAAGTGAGTT
>PA544551.1 JP 2022519312-A/2: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAAGTGAGTG
>PA544550.1 JP 2022519312-A/1: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAAGTAAGTA
>PA544503.1 JP 2022519296-A/76: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
TGGGTACCTG
>PA544502.1 JP 2022519296-A/75: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GGGGTAAGTG
>PA544494.1 JP 2022519296-A/67: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GTTTTGGTGA
>PA544492.1 JP 2022519296-A/65: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GTGGTAAGTG
>PA544491.1 JP 2022519296-A/64: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GGGGTTGGGA
>PA544490.1 JP 2022519296-A/63: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GGGGTGAGTG
>PA544489.1 JP 2022519296-A/62: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GGGGTAAGTG
>PA544488.1 JP 2022519296-A/61: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GCGGTGAGCT
>PA544487.1 JP 2022519296-A/60: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GCGGTGAGCA
>PA544486.1 JP 2022519296-A/59: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GCGGTAATCA
>PA544485.1 JP 2022519296-A/58: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTGCGGG
>PA544484.1 JP 2022519296-A/57: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTCTGGT
>PA544483.1 JP 2022519296-A/56: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTAATGT
>PA544482.1 JP 2022519296-A/55: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTAATAT
>PA544481.1 JP 2022519296-A/54: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTAATAC
>PA544480.1 JP 2022519296-A/53: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTAAGCG
>PA544479.1 JP 2022519296-A/52: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTAAGAG
>PA544475.1 JP 2022519296-A/48: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CTGGTGAGTC
>PA544473.1 JP 2022519296-A/46: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CATGGAAGAC
>PA544472.1 JP 2022519296-A/45: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTTTAGT
>PA544471.1 JP 2022519296-A/44: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTGGGTG
>PA544469.1 JP 2022519296-A/42: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTGAGGG
>PA544468.1 JP 2022519296-A/41: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTCTGGT
>PA544467.1 JP 2022519296-A/40: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTCTGGA
>PA544466.1 JP 2022519296-A/39: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTCAGTG
>PA544463.1 JP 2022519296-A/36: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAGCAA
>PA544462.1 JP 2022519296-A/35: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTACAGT
>PA544461.1 JP 2022519296-A/34: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAATGT
>PA544460.1 JP 2022519296-A/33: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAATGC
>PA544459.1 JP 2022519296-A/32: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAAGAC
>PA544457.1 JP 2022519296-A/30: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAAGGC
>PA544456.1 JP 2022519296-A/29: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAAGTAAGTA
>PA544455.1 JP 2022519296-A/28: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAAGGTACCT
>PA544454.1 JP 2022519296-A/27: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
ATCGGTAAAA
>PA544452.1 JP 2022519296-A/25: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AGGGTAATGA
>PA544451.1 JP 2022519296-A/24: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
ACTGTGAGTG
>PA544450.1 JP 2022519296-A/23: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
ACGGTGAGTG
>PA544449.1 JP 2022519296-A/22: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
ACCGTGAGTT
>PA544448.1 JP 2022519296-A/21: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTTAGTG
>PA544447.1 JP 2022519296-A/20: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTGGGCC
>PA544446.1 JP 2022519296-A/19: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTGAGTC
>PA544445.1 JP 2022519296-A/18: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTGAGAT
>PA544443.1 JP 2022519296-A/16: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTCTGGG
>PA544442.1 JP 2022519296-A/15: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTATATT
>PA544441.1 JP 2022519296-A/14: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAGACC
>PA544439.1 JP 2022519296-A/12: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAATGT
>PA544438.1 JP 2022519296-A/11: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAATAA
>PA544437.1 JP 2022519296-A/10: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAAGCG
>PA544436.1 JP 2022519296-A/9: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAAGCC
>PA544434.1 JP 2022519296-A/7: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTATGAG
>PA544433.1 JP 2022519296-A/6: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGCAGGGA
>PA544432.1 JP 2022519296-A/5: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGCAAGGG
>PA544431.1 JP 2022519296-A/4: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AACATGAGGA
>PA544430.1 JP 2022519296-A/3: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAAGTGAGTT
>PA544429.1 JP 2022519296-A/2: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAAGTGAGTG
>PA544428.1 JP 2022519296-A/1: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAAGTAAGTA
>PA543505.1 WO 2022085756-A/18: Tokenized gene sequence generating device, gene corpus generating device and program
GGTTGTCGGG
>PA543504.1 WO 2022085756-A/17: Tokenized gene sequence generating device, gene corpus generating device and program
ATCAGTCCCA
>PA543503.1 WO 2022085756-A/16: Tokenized gene sequence generating device, gene corpus generating device and program
GAAACCGGGG
>PA543502.1 WO 2022085756-A/15: Tokenized gene sequence generating device, gene corpus generating device and program
TAGGTCATCC
>PA543497.1 WO 2022085756-A/10: Tokenized gene sequence generating device, gene corpus generating device and program
CTCAGTTCCT
>PA544500.1 JP 2022519296-A/73: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAAGGC
>PA544499.1 JP 2022519296-A/72: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTATGAG
>PA544498.1 JP 2022519296-A/71: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
TGGGTGGGTG
>PA544497.1 JP 2022519296-A/70: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
TGGGTGGGGG
>PA544496.1 JP 2022519296-A/69: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
TGGGTACCTG
>pdb|7RIX|R Chain R, RNA polymerase II elongation complex with hairpin polyamide Py-Im 1, scaffold 2
ATCGAGAGGC
>pdb|7RIW|R Chain R, RNA polymerase II elongation complex scaffold 2, without polyamide
ATCGAGAGGC
>pdb|7RIP|R Chain R, RNA polymerase II elongation complex with hairpin polyamide Py-Im 1, scaffold 1 soaked with CTP
ATCGAGAGGC
>pdb|7RIL|B Chain B, Crystal structure of hairpin polyamide Py-Im 1 bound to 5' CCTGACCAGG
CCTGGTCAGG
>pdb|7RIL|A Chain A, Crystal structure of hairpin polyamide Py-Im 1 bound to 5' CCTGACCAGG
CCTGACCAGG
>pdb|6XGO|B Chain B, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J34 immobile Holliday junction
NCTCCACTCA
>pdb|6XGN|B Chain B, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J33 immobile Holliday junction
NCAGCACTCA
>pdb|6XGM|B Chain B, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J25 immobile Holliday junction
NCCGCACTCA
>pdb|6XGL|B Chain B, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J36 immobile Holliday junction
NCACCACTCA
>pdb|6XGK|B Chain B, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J35 immobile Holliday junction
NCTGCACTCA
>pdb|6XGJ|B Chain B, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J32 immobile Holliday junction
NCACCACTCA
>pdb|6XG0|B Chain B, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J31 immobile Holliday junction
NCGCCACTCA
>pdb|6XFZ|B Chain B, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J29 immobile Holliday junction
NCTGCACTCA
>pdb|6XFY|B Chain B, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J28 immobile Holliday junction
NCTCCACTCA
>pdb|6XFX|B Chain B, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J26 immobile Holliday junction
NCACCACTCA
>pdb|6XFW|B Chain B, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J24 immobile Holliday junction
NCTCCACTCA
>pdb|6XFG|B Chain B, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J23 immobile Holliday junction
NCACCACTCA
>pdb|6XFF|B Chain B, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J22 immobile Holliday junction
NCGCCACTCA
>pdb|6XFE|B Chain B, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J21 immobile Holliday junction
NCTGCACTCA
>pdb|6XFD|B Chain B, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J20 immobile Holliday junction
NCAGCACTCA
>pdb|6XFC|B Chain B, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J19 immobile Holliday junction
NCTCCACTCA
>pdb|6XEM|B Chain B, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J16 immobile Holliday junction
NCCCCACTCA
>pdb|6XEL|B Chain B, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J15 immobile Holliday junction
NCCGCACTCA
>pdb|6XEK|B Chain B, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J14 immobile Holliday junction
NCCCCACTCA
>pdb|6XEJ|B Chain B, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J10 immobile Holliday junction
NCTCCACTCA
>pdb|6XEI|B Chain B, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J9 immobile Holliday junction
NCTGCACTCA
>pdb|6XDZ|B Chain B, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J8 immobile Holliday junction
NCACCACTCA
>pdb|6XDY|B Chain B, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J7 immobile Holliday junction
NCGTCACTCA
>pdb|6XDX|B Chain B, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J6 immobile Holliday junction
NCTTCACTCA
>pdb|6XDW|B Chain B, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J5 immobile Holliday junction
NCGGCACTCA
>pdb|6XDV|B Chain B, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J3 immobile Holliday junction
NCTCCACTCA
>pdb|6X8C|B Chain B, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J1 immobile Holliday junction
NCGACACTCA
>PA539963.1 JP 2022502046-A/22745: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY
AATCAACAAC
>PA539962.1 JP 2022502046-A/22744: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY
TATTAACGGT
>PA539961.1 JP 2022502046-A/22743: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY
NNKNNKCAAC
>PA539960.1 JP 2022502046-A/22742: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY
TATTNNKNNK
>PA541867.1 WO 2022065413-A/8: Novel Artificial Nucleic Acids, Production Method Thereof and Use
TTTTTTTTTT
>PA541864.1 WO 2022065413-A/5: Novel Artificial Nucleic Acids, Production Method Thereof and Use
TTTTTTTTNT
>pdb|7SP1|Q Chain Q, RNA-induced tau amyloid fibril
AAAAAAAAAA
>pdb|7SP1|P Chain P, RNA-induced tau amyloid fibril
AAAAAAAAAA
>pdb|2Y1J|C Chain C, CRYSTAL STRUCTURE OF A R-DIASTEREOMER ANALOGUE OF THE SPORE PHOTOPRODUCT IN COMPLEX WITH FRAGMENT DNA POLYMERASE I FROM BACILLUS STEAROTHERMOPHILUS
AGGGNNGGTC
>pdb|2Y1J|B Chain B, CRYSTAL STRUCTURE OF A R-DIASTEREOMER ANALOGUE OF THE SPORE PHOTOPRODUCT IN COMPLEX WITH FRAGMENT DNA POLYMERASE I FROM BACILLUS STEAROTHERMOPHILUS
GACCAACCCT
>pdb|1I0O|B Chain B, 1.6 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-METHYL-3'-METHYLENEPHOSPHONATE THYMINE IN PLACE OF T6, HIGH K-SALT
GCGTANACGC
>pdb|1I0O|A Chain A, 1.6 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-METHYL-3'-METHYLENEPHOSPHONATE THYMINE IN PLACE OF T6, HIGH K-SALT
GCGTANACGC
>pdb|1I0J|B Chain B, 1.06 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-METHYL-3'-METHYLENEPHOSPHONATE (T23) THYMINE IN PLACE OF T6, HIGH CS-SALT
GCGTANACGC
>pdb|1I0J|A Chain A, 1.06 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-METHYL-3'-METHYLENEPHOSPHONATE (T23) THYMINE IN PLACE OF T6, HIGH CS-SALT
GCGTANACGC
>pdb|1DPL|B Chain B, A-DNA DECAMER GCGTA(T23)TACGC WITH INCORPORATED 2'-METHOXY-3'-METHYLENEPHOSPHATE-THYMIDINE
GCGTANACGC
>pdb|1DPL|A Chain A, A-DNA DECAMER GCGTA(T23)TACGC WITH INCORPORATED 2'-METHOXY-3'-METHYLENEPHOSPHATE-THYMIDINE
GCGTANACGC
>pdb|7NBU|X Chain X, Structure of the HigB1 toxin mutant K95A from Mycobacterium tuberculosis (Rv1955) and its target, the cspA mRNA, on the E. coli Ribosome.
NATATGCCAC
>pdb|7MZ3|P Chain P, Structure of human DNA polymerase beta complexed with 3-deaza-3-methyladenine (3dMeA) as the template base in a 1-nucleotide gapped DNA
GCTGATGCGA
>pdb|7MZ4|P Chain P, Structure of human DNA polymerase beta complexed with 3-deaza-3-methyladenine (3dMeA) in the template base paired with incoming dTTP
GCTGATGCGA
>pdb|7MZ8|P Chain P, Structure of human DNA polymerase beta complexed with 3-deaza-3-methyladenine (3dMeA) at N-1 of the template base paired with incoming dTTP
GCTGATGCGT
>pdb|7TOQ|MRNA Chain MRNA, Mammalian 80S ribosome bound with the ALS/FTD-associated dipeptide repeat protein poly-PR
NACATGTTCC
>pdb|7MZ2|P Chain P, Structure of human DNA polymerase beta complexed with dzA at N-1 of the template base paired with incoming dTTP
GCTGATGCGT
>pdb|7MZ1|P Chain P, Structure of human DNA polymerase beta complexed with dzA in the template base paired with incoming non-hydrolyzable TTP
GCTGATGCGA
>pdb|7MZ0|P Chain P, Structure of human DNA polymerase beta complexed with dzA as the template base in a 1-nucleotide gapped DNA
GCTGATGCGA
>OF297817.1 KR 1020210133626-A/10: Medium composition for in vitro culture of Prunus africana and mass production method of Prunus africana using the same
GGCTTGTGCC
>OF297816.1 KR 1020210133626-A/9: Medium composition for in vitro culture of Prunus africana and mass production method of Prunus africana using the same
CCGAACACGG
>OF297815.1 KR 1020210133626-A/8: Medium composition for in vitro culture of Prunus africana and mass production method of Prunus africana using the same
GGCGGATCAG
>OF337919.1 KR 1020210129105-A/1: MODIFIED NATURAL KILLER (NK) CELLS FOR IMMUNOTHERAPY
AAGACCTTTT
>OF337518.1 KR 1020210124362-A/71: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
TGGGTGGGTG
>OF337517.1 KR 1020210124362-A/70: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
TGGGTGGGGG
>OF337516.1 KR 1020210124362-A/69: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
TGGGTACCTG
>OF337514.1 KR 1020210124362-A/67: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GTTTTGGTGA
>OF337512.1 KR 1020210124362-A/65: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GTGGTAAGTG
>OF337511.1 KR 1020210124362-A/64: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GGGGTTGGGA
>OF337510.1 KR 1020210124362-A/63: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GGGGTGAGTG
>OF337509.1 KR 1020210124362-A/62: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GGGGTAAGTG
>OF337508.1 KR 1020210124362-A/61: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GCGGTGAGCT
>OF337507.1 KR 1020210124362-A/60: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GCGGTGAGCA
>OF337506.1 KR 1020210124362-A/59: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GCGGTAATCA
>OF337505.1 KR 1020210124362-A/58: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTGCGGG
>OF337504.1 KR 1020210124362-A/57: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTCTGGT
>OF337503.1 KR 1020210124362-A/56: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTAATGT
>OF337502.1 KR 1020210124362-A/55: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTAATAT
>OF337501.1 KR 1020210124362-A/54: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTAATAC
>OF337500.1 KR 1020210124362-A/53: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTAAGCG
>OF337499.1 KR 1020210124362-A/52: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTAAGAG
>OF337495.1 KR 1020210124362-A/48: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CTGGTGAGTC
>OF337493.1 KR 1020210124362-A/46: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CATGGAAGAC
>OF337492.1 KR 1020210124362-A/45: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTTTAGT
>OF337491.1 KR 1020210124362-A/44: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTGGGTG
>OF337489.1 KR 1020210124362-A/42: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTGAGGG
>OF337488.1 KR 1020210124362-A/41: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTCTGGT
>OF337487.1 KR 1020210124362-A/40: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTCTGGA
>OF337486.1 KR 1020210124362-A/39: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTCAGTG
>OF337483.1 KR 1020210124362-A/36: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAGCAA
>OF337482.1 KR 1020210124362-A/35: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTACAGT
>OF337481.1 KR 1020210124362-A/34: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAATGT
>OF337480.1 KR 1020210124362-A/33: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAATGC
>OF337479.1 KR 1020210124362-A/32: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAAGAC
>OF337477.1 KR 1020210124362-A/30: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAAGGC
>OF337476.1 KR 1020210124362-A/29: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAAGTAAGTA
>OF337475.1 KR 1020210124362-A/28: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAAGGTACCT
>OF337474.1 KR 1020210124362-A/27: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
ATCGGTAAAA
>OF337472.1 KR 1020210124362-A/25: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AGGGTAATGA
>OF337471.1 KR 1020210124362-A/24: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
ACTGTGAGTG
>OF337470.1 KR 1020210124362-A/23: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
ACGGTGAGTG
>OF337469.1 KR 1020210124362-A/22: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
ACCGTGAGTT
>OF337468.1 KR 1020210124362-A/21: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTTAGTG
>OF337467.1 KR 1020210124362-A/20: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTGGGCC
>OF337466.1 KR 1020210124362-A/19: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTGAGTC
>OF337465.1 KR 1020210124362-A/18: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTGAGAT
>OF337463.1 KR 1020210124362-A/16: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTCTGGG
>OF337462.1 KR 1020210124362-A/15: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTATATT
>OF337461.1 KR 1020210124362-A/14: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAGACC
>OF337459.1 KR 1020210124362-A/12: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAATGT
>OF337458.1 KR 1020210124362-A/11: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAATAA
>OF337457.1 KR 1020210124362-A/10: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAAGCG
>OF337456.1 KR 1020210124362-A/9: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAAGCC
>OF337454.1 KR 1020210124362-A/7: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTATGAG
>OF337453.1 KR 1020210124362-A/6: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGCAGGGA
>OF337452.1 KR 1020210124362-A/5: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGCAAGGG
>OF337451.1 KR 1020210124362-A/4: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AACATGAGGA
>OF337450.1 KR 1020210124362-A/3: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAAGTGAGTT
>OF337449.1 KR 1020210124362-A/2: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAAGTGAGTG
>OF337448.1 KR 1020210124362-A/1: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAAGTAAGTA
>OF336611.1 KR 1020210111887-A/102: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
GAGACTGTAC
>OF336608.1 KR 1020210111887-A/99: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
GAGAGTGTAC
>OF336607.1 KR 1020210111887-A/98: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
GAGACCGTAC
>OF336606.1 KR 1020210111887-A/97: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
GAGATTGTAC
>OF336605.1 KR 1020210111887-A/96: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
GAGACTGTAC
>OF336604.1 KR 1020210111887-A/95: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
GAGATTGTAC
>OF336603.1 KR 1020210111887-A/94: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
GAGAATGTAC
>OF336602.1 KR 1020210111887-A/93: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
GAGAGTGTAC
>OF336601.1 KR 1020210111887-A/92: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
GAGACGGTAC
>OF336600.1 KR 1020210111887-A/91: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
GAGACCGTAC
>OF336599.1 KR 1020210111887-A/90: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
GAGACAGTAC
>OF336598.1 KR 1020210111887-A/89: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
GAGACTGTAC
>OF336597.1 KR 1020210111887-A/88: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
GCTTGACCAA
>OF336596.1 KR 1020210111887-A/87: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
GCTCGACCAA
>OF336595.1 KR 1020210111887-A/86: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
GCTGGACCAA
>OF336594.1 KR 1020210111887-A/85: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
GCTAGACCAA
>OF336593.1 KR 1020210111887-A/84: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
CGATCTGGTT
>OF336592.1 KR 1020210111887-A/83: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
CGATCTGGTT
>OF336533.1 KR 1020210111887-A/24: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
TCATTGAATG
>OF336532.1 KR 1020210111887-A/23: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
ACTAATGTTC
>OF336531.1 KR 1020210111887-A/22: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
TAACTATGAC
>OF336530.1 KR 1020210111887-A/21: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
AACTATGTAC
>OF336529.1 KR 1020210111887-A/20: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
TTAACAAGTG
>OF336528.1 KR 1020210111887-A/19: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
TGTACTATAG
>OF336527.1 KR 1020210111887-A/18: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
ATACGTTATG
>OF336526.1 KR 1020210111887-A/17: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
TTAAGTTTAG
>OF336525.1 KR 1020210111887-A/16: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
TATAACGATG
>OF336524.1 KR 1020210111887-A/15: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
ATAGTGATTC
>OF336523.1 KR 1020210111887-A/14: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
TTGATGATAC
>OF336522.1 KR 1020210111887-A/13: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
ATAGAGAAGG
>OF336521.1 KR 1020210111887-A/12: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
TAGTTAGAGC
>OF336520.1 KR 1020210111887-A/11: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
TAATAAGGTG
>OF336519.1 KR 1020210111887-A/10: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
ATAATGGATC
>OF336518.1 KR 1020210111887-A/9: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
AATTAGGATG
>OF336517.1 KR 1020210111887-A/8: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
ATGTTAATGG
>OF336516.1 KR 1020210111887-A/7: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
AATTGAGTAC
>OF336515.1 KR 1020210111887-A/6: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
TCAATGTATG
>OF336514.1 KR 1020210111887-A/5: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
ATGAATCTAC
>OF336513.1 KR 1020210111887-A/4: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
TCTTCATTAC
>OF336512.1 KR 1020210111887-A/3: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
TTAGGTAAAG
>OF336511.1 KR 1020210111887-A/2: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
GATCTACATA
>OF336510.1 KR 1020210111887-A/1: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
ATACATCTAG
>OF336509.1 KR 1020210123344-A/71: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
TGGGTGGGTG
>OF336508.1 KR 1020210123344-A/70: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
TGGGTGGGGG
>OF336507.1 KR 1020210123344-A/69: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
TGGGTACCTG
>OF336505.1 KR 1020210123344-A/67: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GTTTTGGTGA
>OF336503.1 KR 1020210123344-A/65: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GTGGTAAGTG
>OF336502.1 KR 1020210123344-A/64: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GGGGTTGGGA
>OF336501.1 KR 1020210123344-A/63: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GGGGTGAGTG
>OF336500.1 KR 1020210123344-A/62: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GGGGTAAGTG
>OF336499.1 KR 1020210123344-A/61: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GCGGTGAGCT
>OF336498.1 KR 1020210123344-A/60: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GCGGTGAGCA
>OF336497.1 KR 1020210123344-A/59: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GCGGTAATCA
>OF336496.1 KR 1020210123344-A/58: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTGCGGG
>OF336495.1 KR 1020210123344-A/57: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTCTGGT
>OF336494.1 KR 1020210123344-A/56: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTAATGT
>OF336493.1 KR 1020210123344-A/55: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTAATAT
>OF336492.1 KR 1020210123344-A/54: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTAATAC
>OF336491.1 KR 1020210123344-A/53: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTAAGCG
>OF336490.1 KR 1020210123344-A/52: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTAAGAG
>OF336486.1 KR 1020210123344-A/48: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CTGGTGAGTC
>OF336484.1 KR 1020210123344-A/46: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CATGGAAGAC
>OF336483.1 KR 1020210123344-A/45: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTTTAGT
>OF336482.1 KR 1020210123344-A/44: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTGGGTG
>OF336480.1 KR 1020210123344-A/42: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTGAGGG
>OF336479.1 KR 1020210123344-A/41: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTCTGGT
>OF336478.1 KR 1020210123344-A/40: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTCTGGA
>OF336477.1 KR 1020210123344-A/39: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTCAGTG
>OF336474.1 KR 1020210123344-A/36: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAGCAA
>OF336473.1 KR 1020210123344-A/35: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTACAGT
>OF336472.1 KR 1020210123344-A/34: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAATGT
>OF336471.1 KR 1020210123344-A/33: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAATGC
>OF336470.1 KR 1020210123344-A/32: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAAGAC
>OF336468.1 KR 1020210123344-A/30: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAAGGC
>OF336467.1 KR 1020210123344-A/29: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAAGTAAGTA
>OF336466.1 KR 1020210123344-A/28: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAAGGTACCT
>OF336465.1 KR 1020210123344-A/27: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
ATCGGTAAAA
>OF336463.1 KR 1020210123344-A/25: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AGGGTAATGA
>OF336462.1 KR 1020210123344-A/24: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
ACTGTGAGTG
>OF336461.1 KR 1020210123344-A/23: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
ACGGTGAGTG
>OF336460.1 KR 1020210123344-A/22: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
ACCGTGAGTT
>OF336459.1 KR 1020210123344-A/21: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTTAGTG
>OF336458.1 KR 1020210123344-A/20: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTGGGCC
>OF336457.1 KR 1020210123344-A/19: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTGAGTC
>OF336456.1 KR 1020210123344-A/18: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTGAGAT
>OF336454.1 KR 1020210123344-A/16: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTCTGGG
>OF336453.1 KR 1020210123344-A/15: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTATATT
>OF336452.1 KR 1020210123344-A/14: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAGACC
>OF336450.1 KR 1020210123344-A/12: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAATGT
>OF336449.1 KR 1020210123344-A/11: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAATAA
>OF336448.1 KR 1020210123344-A/10: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAAGCG
>OF336447.1 KR 1020210123344-A/9: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAAGCC
>OF336445.1 KR 1020210123344-A/7: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTATGAG
>OF336444.1 KR 1020210123344-A/6: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGCAGGGA
>OF336443.1 KR 1020210123344-A/5: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGCAAGGG
>OF336442.1 KR 1020210123344-A/4: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AACATGAGGA
>OF336441.1 KR 1020210123344-A/3: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAAGTGAGTT
>OF336440.1 KR 1020210123344-A/2: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAAGTGAGTG
>OF336439.1 KR 1020210123344-A/1: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAAGTAAGTA
>OF336358.1 KR 1020210130158-A/463: METHODS FOR USING TRANSCRIPTION-DEPENDENT DIRECTED EVOLUTION OF AAV CAPSIDS
GGGAGCTACA
>OF336117.1 KR 1020210130158-A/220: METHODS FOR USING TRANSCRIPTION-DEPENDENT DIRECTED EVOLUTION OF AAV CAPSIDS
GGGAGCTGCA
>OF336116.1 KR 1020210130158-A/219: METHODS FOR USING TRANSCRIPTION-DEPENDENT DIRECTED EVOLUTION OF AAV CAPSIDS
AAACACTGCA
>OF336115.1 KR 1020210130158-A/218: METHODS FOR USING TRANSCRIPTION-DEPENDENT DIRECTED EVOLUTION OF AAV CAPSIDS
CGTTTCTAAA
>OF336114.1 KR 1020210130158-A/217: METHODS FOR USING TRANSCRIPTION-DEPENDENT DIRECTED EVOLUTION OF AAV CAPSIDS
ACTACCTGAA
>OF336113.1 KR 1020210130158-A/216: METHODS FOR USING TRANSCRIPTION-DEPENDENT DIRECTED EVOLUTION OF AAV CAPSIDS
ACTGCCTGGA
>OF336112.1 KR 1020210130158-A/215: METHODS FOR USING TRANSCRIPTION-DEPENDENT DIRECTED EVOLUTION OF AAV CAPSIDS
TCACCCTGAA
>OF336111.1 KR 1020210130158-A/214: METHODS FOR USING TRANSCRIPTION-DEPENDENT DIRECTED EVOLUTION OF AAV CAPSIDS
GCCCGCTAAA
>OF336110.1 KR 1020210130158-A/213: METHODS FOR USING TRANSCRIPTION-DEPENDENT DIRECTED EVOLUTION OF AAV CAPSIDS
GGCTCCTGGA
>OF336109.1 KR 1020210130158-A/212: METHODS FOR USING TRANSCRIPTION-DEPENDENT DIRECTED EVOLUTION OF AAV CAPSIDS
AGCGTCTGCA
>OF336108.1 KR 1020210130158-A/211: METHODS FOR USING TRANSCRIPTION-DEPENDENT DIRECTED EVOLUTION OF AAV CAPSIDS
CTCACACGAA
>OF336107.1 KR 1020210130158-A/210: METHODS FOR USING TRANSCRIPTION-DEPENDENT DIRECTED EVOLUTION OF AAV CAPSIDS
CTTACCCGTC
>OF336106.1 KR 1020210130158-A/209: METHODS FOR USING TRANSCRIPTION-DEPENDENT DIRECTED EVOLUTION OF AAV CAPSIDS
GATACCTGAC
>OF336105.1 KR 1020210130158-A/208: METHODS FOR USING TRANSCRIPTION-DEPENDENT DIRECTED EVOLUTION OF AAV CAPSIDS
GTTACCTTAC
>OF336104.1 KR 1020210130158-A/207: METHODS FOR USING TRANSCRIPTION-DEPENDENT DIRECTED EVOLUTION OF AAV CAPSIDS
TGTACCTGCA
>OF336103.1 KR 1020210130158-A/206: METHODS FOR USING TRANSCRIPTION-DEPENDENT DIRECTED EVOLUTION OF AAV CAPSIDS
CTTACCTGGC
>OF336102.1 KR 1020210130158-A/205: METHODS FOR USING TRANSCRIPTION-DEPENDENT DIRECTED EVOLUTION OF AAV CAPSIDS
ATTACCTGGC
>OF336101.1 KR 1020210130158-A/204: METHODS FOR USING TRANSCRIPTION-DEPENDENT DIRECTED EVOLUTION OF AAV CAPSIDS
TTTACCTGGA
>OF336100.1 KR 1020210130158-A/203: METHODS FOR USING TRANSCRIPTION-DEPENDENT DIRECTED EVOLUTION OF AAV CAPSIDS
GCTACCTGGA
>OF336099.1 KR 1020210130158-A/202: METHODS FOR USING TRANSCRIPTION-DEPENDENT DIRECTED EVOLUTION OF AAV CAPSIDS
ATTACCTGAA
>OF336098.1 KR 1020210130158-A/201: METHODS FOR USING TRANSCRIPTION-DEPENDENT DIRECTED EVOLUTION OF AAV CAPSIDS
TATACCTTCG
>OF336097.1 KR 1020210130158-A/200: METHODS FOR USING TRANSCRIPTION-DEPENDENT DIRECTED EVOLUTION OF AAV CAPSIDS
TTTACCTTCA
>OF336096.1 KR 1020210130158-A/199: METHODS FOR USING TRANSCRIPTION-DEPENDENT DIRECTED EVOLUTION OF AAV CAPSIDS
CTTACCAGCA
>OF336087.1 KR 1020210130158-A/190: METHODS FOR USING TRANSCRIPTION-DEPENDENT DIRECTED EVOLUTION OF AAV CAPSIDS
CGAGCCAACC
>OF330256.1 KR 1020210133215-A/19: A METHOD FOR SUPPRESSING NON-SPECIFIC AMPLIFICATION PRODUCTS IN NUCLEIC ACID AMPLIFICATION TECHNOLOGIES
CATCTCGGAA
>OF330255.1 KR 1020210133215-A/18: A METHOD FOR SUPPRESSING NON-SPECIFIC AMPLIFICATION PRODUCTS IN NUCLEIC ACID AMPLIFICATION TECHNOLOGIES
GAACGTGGTA
>OF330254.1 KR 1020210133215-A/17: A METHOD FOR SUPPRESSING NON-SPECIFIC AMPLIFICATION PRODUCTS IN NUCLEIC ACID AMPLIFICATION TECHNOLOGIES
CAAAAATGCG
>OF330253.1 KR 1020210133215-A/16: A METHOD FOR SUPPRESSING NON-SPECIFIC AMPLIFICATION PRODUCTS IN NUCLEIC ACID AMPLIFICATION TECHNOLOGIES
TCAGCTCCAG
>OF328667.1 KR 1020210108994-A/203: MUTATED TRNA FOR CODON EXPANSION
CCCTTATACG
>OF328666.1 KR 1020210108994-A/202: MUTATED TRNA FOR CODON EXPANSION
CCCTNATACG
>OF328664.1 KR 1020210108994-A/200: MUTATED TRNA FOR CODON EXPANSION
CCCTTCCACG
>OF328663.1 KR 1020210108994-A/199: MUTATED TRNA FOR CODON EXPANSION
CCCTNCCACG
>OF328662.1 KR 1020210108994-A/198: MUTATED TRNA FOR CODON EXPANSION
CCCTTACACG
>OF328661.1 KR 1020210108994-A/197: MUTATED TRNA FOR CODON EXPANSION
CCCTNACACG
>OF327908.1 KR 1020210108426-A/190: COMPOSITIONS AND METHODS FOR DETECTING PLASMODIUM SPECIES NUCLEIC ACID
ATTCGCGCAA
>OF327906.1 KR 1020210108426-A/178: COMPOSITIONS AND METHODS FOR DETECTING PLASMODIUM SPECIES NUCLEIC ACID
ATTTTCTGGA
>OF327905.1 KR 1020210108426-A/177: COMPOSITIONS AND METHODS FOR DETECTING PLASMODIUM SPECIES NUCLEIC ACID
YTCTGGAGAC
>OF327824.1 KR 1020210125999-A/25: GENE THERAPY VECTORS FOR TREATMENT OF DANON DISEASE
GACACCATGG
>OF327025.1 KR 1020210125990-A/147: ANELLOSOMES FOR DELIVERING PROTEIN REPLACEMENT THERAPEUTIC MODALITIES
CGCCGGGGGG
>OF326307.1 KR 1020210143716-A/8: HYBRID PROMOTERS AND THEIR USES IN THERAPY, NOTABLY FOR TREATING TYPE II COLLAGENOPATHIES
GGGCTGCCGG
>OF325967.1 KR 1020210102309-A/40: REDUCED AND MINIMAL MANIPULATION MANUFACTURING OF GENETICALLY-MODIFIED CELLS
GTTTGCCTTG
>OF321166.1 KR 1020210101227-A/30: PLANT VECTORS, COMPOSITIONS AND USES RELATING THERETO
GTCCTAAGTC
>OF360497.1 KR 1020210158859-A/25: UBE3A GENES AND EXPRESSION CASSETTES AND THEIR USE
AGCAGGATGA
>OF360496.1 KR 1020210158859-A/24: UBE3A GENES AND EXPRESSION CASSETTES AND THEIR USE
GCCRCCATGG
>OF360486.1 KR 1020210158859-A/8: UBE3A GENES AND EXPRESSION CASSETTES AND THEIR USE
AGCAGGATGA
>OF360485.1 KR 1020210158859-A/7: UBE3A GENES AND EXPRESSION CASSETTES AND THEIR USE
AGCCGAATGA
>OF360484.1 KR 1020210158859-A/6: UBE3A GENES AND EXPRESSION CASSETTES AND THEIR USE
TTTTTTATGG
>OF360483.1 KR 1020210158859-A/5: UBE3A GENES AND EXPRESSION CASSETTES AND THEIR USE
CACCGAATGG
>OF360482.1 KR 1020210158859-A/4: UBE3A GENES AND EXPRESSION CASSETTES AND THEIR USE
TGCAGGATGG
>OF355366.1 KR 1020210138766-A/19: PROMOTER REGION ANALYSIS METHODS AND CELLS FOR PRACTICING SAME
TAATATTTTT
>OF355365.1 KR 1020210138766-A/18: PROMOTER REGION ANALYSIS METHODS AND CELLS FOR PRACTICING SAME
AAACATTTTG
>OF315035.1 KR 1020210091180-A/10618: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAG
>OF314921.1 KR 1020210091180-A/10504: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATT
>OF314913.1 KR 1020210091180-A/10496: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCAT
>OF314905.1 KR 1020210091180-A/10488: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCA
>OF314898.1 KR 1020210091180-A/10481: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGC
>OF314872.1 KR 1020210091180-A/10455: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGAT
>OF314859.1 KR 1020210091180-A/10442: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGA
>OF314812.1 KR 1020210091180-A/10395: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGT
>OF314800.1 KR 1020210091180-A/10383: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTT
>OF314787.1 KR 1020210091180-A/10370: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTC
>OF314775.1 KR 1020210091180-A/10358: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCT
>OF314763.1 KR 1020210091180-A/10346: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTG
>OF314751.1 KR 1020210091180-A/10334: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGT
>OF314739.1 KR 1020210091180-A/10322: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTC
>OF314726.1 KR 1020210091180-A/10309: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCC
>OF314713.1 KR 1020210091180-A/10296: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCA
>OF314700.1 KR 1020210091180-A/10283: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGC
>OF355114.1 KR 1020210153632-A/3: COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS
GAGGTAAGTA
>OF355113.1 KR 1020210153632-A/2: COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS
TACNNACCTG
>OF355112.1 KR 1020210153632-A/1: COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS
CAGGTAAGTA
>OF354977.1 KR 1020210143856-A/1: GENETICALLY REPROGRAMMED TREGS EXPRESSING CARS
CGGAAAGACC
>OF314690.1 KR 1020210091180-A/10273: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAG
>OF314678.1 KR 1020210091180-A/10261: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAA
>OF314662.1 KR 1020210091180-A/10245: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAG
>OF314548.1 KR 1020210091180-A/10131: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATT
>OF314540.1 KR 1020210091180-A/10123: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCAT
>OF314532.1 KR 1020210091180-A/10115: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCA
>OF314525.1 KR 1020210091180-A/10108: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGC
>OF314486.1 KR 1020210091180-A/10069: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGA
>OF314499.1 KR 1020210091180-A/10082: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGAT
>OF314439.1 KR 1020210091180-A/10022: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGT
>OF314427.1 KR 1020210091180-A/10010: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTT
>OF314414.1 KR 1020210091180-A/9997: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTC
>OF314402.1 KR 1020210091180-A/9985: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCT
>OF314390.1 KR 1020210091180-A/9973: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTG
>OF314378.1 KR 1020210091180-A/9961: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGT
>OF314366.1 KR 1020210091180-A/9949: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTC
>OF314353.1 KR 1020210091180-A/9936: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCC
>OF314340.1 KR 1020210091180-A/9923: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCA
>OF314327.1 KR 1020210091180-A/9910: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGC
>OF314317.1 KR 1020210091180-A/9900: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAG
>OF314305.1 KR 1020210091180-A/9888: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAA
>OF314289.1 KR 1020210091180-A/9872: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAG
>OF314175.1 KR 1020210091180-A/9758: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATT
>OF314167.1 KR 1020210091180-A/9750: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCAT
>OF314159.1 KR 1020210091180-A/9742: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCA
>OF314152.1 KR 1020210091180-A/9735: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGC
>OF314126.1 KR 1020210091180-A/9709: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGAT
>OF314113.1 KR 1020210091180-A/9696: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGA
>OF314066.1 KR 1020210091180-A/9649: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGT
>OF314054.1 KR 1020210091180-A/9637: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTT
>OF314041.1 KR 1020210091180-A/9624: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTC
>OF314029.1 KR 1020210091180-A/9612: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCT
>OF314017.1 KR 1020210091180-A/9600: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTG
>OF314005.1 KR 1020210091180-A/9588: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGT
>OF313993.1 KR 1020210091180-A/9576: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTC
>OF313980.1 KR 1020210091180-A/9563: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCC
>OF313967.1 KR 1020210091180-A/9550: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCA
>OF313954.1 KR 1020210091180-A/9537: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGC
>OF313944.1 KR 1020210091180-A/9527: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAG
>OF313932.1 KR 1020210091180-A/9515: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAA
>OF313916.1 KR 1020210091180-A/9499: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAG
>OF313802.1 KR 1020210091180-A/9385: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATT
>OF313794.1 KR 1020210091180-A/9377: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCAT
>OF313786.1 KR 1020210091180-A/9369: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCA
>OF313779.1 KR 1020210091180-A/9362: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGC
>OF313753.1 KR 1020210091180-A/9336: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGAT
>OF313740.1 KR 1020210091180-A/9323: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGA
>OF353993.1 KR 1020210131432-A/50: OPTIMIZATION OF MULTIGENE ANALYSIS OF TUMOR SAMPLES
TTAAGAGAAG
>OF313693.1 KR 1020210091180-A/9276: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGT
>OF313681.1 KR 1020210091180-A/9264: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTT
>OF313668.1 KR 1020210091180-A/9251: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTC
>OF313656.1 KR 1020210091180-A/9239: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCT
>OF313644.1 KR 1020210091180-A/9227: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTG
>OF313632.1 KR 1020210091180-A/9215: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGT
>OF313620.1 KR 1020210091180-A/9203: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTC
>OF313607.1 KR 1020210091180-A/9190: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCC
>OF313594.1 KR 1020210091180-A/9177: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCA
>OF313581.1 KR 1020210091180-A/9164: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGC
>OF313571.1 KR 1020210091180-A/9154: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAG
>OF313559.1 KR 1020210091180-A/9142: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAA
>OF313543.1 KR 1020210091180-A/9126: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAG
>OF313429.1 KR 1020210091180-A/9012: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATT
>OF313421.1 KR 1020210091180-A/9004: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCAT
>OF313413.1 KR 1020210091180-A/8996: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCA
>OF313406.1 KR 1020210091180-A/8989: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGC
>OF313380.1 KR 1020210091180-A/8963: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGAT
>OF313367.1 KR 1020210091180-A/8950: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGA
>OF313320.1 KR 1020210091180-A/8903: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGT
>OF313308.1 KR 1020210091180-A/8891: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTT
>OF313295.1 KR 1020210091180-A/8878: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTC
>OF313283.1 KR 1020210091180-A/8866: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCT
>OF313271.1 KR 1020210091180-A/8854: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTG
>OF313259.1 KR 1020210091180-A/8842: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGT
>OF313247.1 KR 1020210091180-A/8830: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTC
>OF313234.1 KR 1020210091180-A/8817: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCC
>OF313221.1 KR 1020210091180-A/8804: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCA
>OF313208.1 KR 1020210091180-A/8791: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGC
>OF313198.1 KR 1020210091180-A/8781: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAG
>OF313186.1 KR 1020210091180-A/8769: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAA
>OF313170.1 KR 1020210091180-A/8753: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAG
>OF313056.1 KR 1020210091180-A/8639: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATT
>OF313048.1 KR 1020210091180-A/8631: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCAT
>OF313040.1 KR 1020210091180-A/8623: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCA
>OF313033.1 KR 1020210091180-A/8616: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGC
>OF313007.1 KR 1020210091180-A/8590: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGAT
>OF312994.1 KR 1020210091180-A/8577: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGA
>OF312947.1 KR 1020210091180-A/8530: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGT
>OF312935.1 KR 1020210091180-A/8518: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTT
>OF312922.1 KR 1020210091180-A/8505: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTC
>OF312910.1 KR 1020210091180-A/8493: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCT
>OF312898.1 KR 1020210091180-A/8481: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTG
>OF312886.1 KR 1020210091180-A/8469: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGT
>OF312874.1 KR 1020210091180-A/8457: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTC
>OF312861.1 KR 1020210091180-A/8444: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCC
>OF312848.1 KR 1020210091180-A/8431: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCA
>OF312835.1 KR 1020210091180-A/8418: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGC
>OF312825.1 KR 1020210091180-A/8408: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAG
>OF312813.1 KR 1020210091180-A/8396: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAA
>OF312797.1 KR 1020210091180-A/8380: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAG
>OF312683.1 KR 1020210091180-A/8266: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATT
>OF312675.1 KR 1020210091180-A/8258: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCAT
>OF312666.1 KR 1020210091180-A/8249: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCA
>OF312658.1 KR 1020210091180-A/8241: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGC
>OF312647.1 KR 1020210091180-A/8230: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGG
>OF312637.1 KR 1020210091180-A/8220: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATG
>OF312626.1 KR 1020210091180-A/8209: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGAT
>OF312613.1 KR 1020210091180-A/8196: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGA
>OF312516.1 KR 1020210091180-A/8099: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTG
>OF312504.1 KR 1020210091180-A/8087: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGT
>OF312528.1 KR 1020210091180-A/8111: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCT
>OF312566.1 KR 1020210091180-A/8149: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGT
>OF312492.1 KR 1020210091180-A/8075: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTC
>OF312554.1 KR 1020210091180-A/8137: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTT
>OF312479.1 KR 1020210091180-A/8062: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCC
>OF312541.1 KR 1020210091180-A/8124: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTC
>OF312466.1 KR 1020210091180-A/8049: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCA
>OF312453.1 KR 1020210091180-A/8036: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGC
>OF312443.1 KR 1020210091180-A/8026: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAG
>OF312431.1 KR 1020210091180-A/8014: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAA
>OF312415.1 KR 1020210091180-A/7998: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAG
>OF312301.1 KR 1020210091180-A/7884: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATT
>OF312293.1 KR 1020210091180-A/7876: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCAT
>OF312284.1 KR 1020210091180-A/7867: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCA
>OF312276.1 KR 1020210091180-A/7859: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGC
>OF312265.1 KR 1020210091180-A/7848: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGG
>OF312255.1 KR 1020210091180-A/7838: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATG
>OF312244.1 KR 1020210091180-A/7827: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGAT
>OF312231.1 KR 1020210091180-A/7814: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGA
>OF312184.1 KR 1020210091180-A/7767: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGT
>OF312172.1 KR 1020210091180-A/7755: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTT
>OF312159.1 KR 1020210091180-A/7742: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTC
>OF312146.1 KR 1020210091180-A/7729: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCT
>OF312134.1 KR 1020210091180-A/7717: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTG
>OF312122.1 KR 1020210091180-A/7705: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGT
>OF312110.1 KR 1020210091180-A/7693: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTC
>OF312097.1 KR 1020210091180-A/7680: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCC
>OF312084.1 KR 1020210091180-A/7667: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCA
>OF312071.1 KR 1020210091180-A/7654: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGC
>OF312061.1 KR 1020210091180-A/7644: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAG
>OF312049.1 KR 1020210091180-A/7632: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAA
>OF312033.1 KR 1020210091180-A/7616: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAG
>OF311919.1 KR 1020210091180-A/7502: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATT
>OF311911.1 KR 1020210091180-A/7494: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCAT
>OF311902.1 KR 1020210091180-A/7485: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCA
>OF311894.1 KR 1020210091180-A/7477: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGC
>OF311883.1 KR 1020210091180-A/7466: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGG
>OF311873.1 KR 1020210091180-A/7456: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATG
>OF311715.1 KR 1020210091180-A/7298: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCC
>OF311862.1 KR 1020210091180-A/7445: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGAT
>OF311849.1 KR 1020210091180-A/7432: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGA
>OF311802.1 KR 1020210091180-A/7385: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGT
>OF311790.1 KR 1020210091180-A/7373: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTT
>OF311777.1 KR 1020210091180-A/7360: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTC
>OF311764.1 KR 1020210091180-A/7347: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCT
>OF311752.1 KR 1020210091180-A/7335: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTG
>OF311740.1 KR 1020210091180-A/7323: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGT
>OF311728.1 KR 1020210091180-A/7311: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTC
>OF311702.1 KR 1020210091180-A/7285: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCA
>OF311689.1 KR 1020210091180-A/7272: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGC
>OF311679.1 KR 1020210091180-A/7262: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAG
>OF311667.1 KR 1020210091180-A/7250: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAA
>OF311651.1 KR 1020210091180-A/7234: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAG
>OF311537.1 KR 1020210091180-A/7120: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATT
>OF311529.1 KR 1020210091180-A/7112: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCAT
>OF311520.1 KR 1020210091180-A/7103: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCA
>OF311512.1 KR 1020210091180-A/7095: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGC
>OF311501.1 KR 1020210091180-A/7084: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGG
>OF311491.1 KR 1020210091180-A/7074: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATG
>OF311480.1 KR 1020210091180-A/7063: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGAT
>OF311467.1 KR 1020210091180-A/7050: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGA
>OF311307.1 KR 1020210091180-A/6890: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGC
>OF311297.1 KR 1020210091180-A/6880: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAG
>OF311285.1 KR 1020210091180-A/6868: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAA
>OF311269.1 KR 1020210091180-A/6852: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAG
>OF311420.1 KR 1020210091180-A/7003: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGT
>OF311408.1 KR 1020210091180-A/6991: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTT
>OF311395.1 KR 1020210091180-A/6978: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTC
>OF311382.1 KR 1020210091180-A/6965: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCT
>OF311370.1 KR 1020210091180-A/6953: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTG
>OF311358.1 KR 1020210091180-A/6941: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGT
>OF311346.1 KR 1020210091180-A/6929: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTC
>OF311333.1 KR 1020210091180-A/6916: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCC
>OF311320.1 KR 1020210091180-A/6903: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCA
>OF311155.1 KR 1020210091180-A/6738: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATT
>OF311147.1 KR 1020210091180-A/6730: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCAT
>OF311138.1 KR 1020210091180-A/6721: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCA
>OF311130.1 KR 1020210091180-A/6713: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGC
>OF311119.1 KR 1020210091180-A/6702: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGG
>OF311109.1 KR 1020210091180-A/6692: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATG
>OF311098.1 KR 1020210091180-A/6681: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGAT
>OF311085.1 KR 1020210091180-A/6668: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGA
>OF311038.1 KR 1020210091180-A/6621: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGT
>OF311026.1 KR 1020210091180-A/6609: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTT
>OF311013.1 KR 1020210091180-A/6596: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTC
>OF311000.1 KR 1020210091180-A/6583: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCT
>OF310988.1 KR 1020210091180-A/6571: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTG
>OF310976.1 KR 1020210091180-A/6559: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGT
>OF310964.1 KR 1020210091180-A/6547: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTC
>OF310951.1 KR 1020210091180-A/6534: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCC
>OF310938.1 KR 1020210091180-A/6521: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCA
>OF310925.1 KR 1020210091180-A/6508: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGC
>OF310915.1 KR 1020210091180-A/6498: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAG
>OF310903.1 KR 1020210091180-A/6486: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAA
>OF310887.1 KR 1020210091180-A/6470: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAG
>OF310773.1 KR 1020210091180-A/6356: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATT
>OF310765.1 KR 1020210091180-A/6348: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCAT
>OF310756.1 KR 1020210091180-A/6339: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCA
>OF310748.1 KR 1020210091180-A/6331: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGC
>OF310737.1 KR 1020210091180-A/6320: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGG
>OF310727.1 KR 1020210091180-A/6310: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATG
>OF310716.1 KR 1020210091180-A/6299: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGAT
>OF310703.1 KR 1020210091180-A/6286: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGA
>OF310656.1 KR 1020210091180-A/6239: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGT
>OF310644.1 KR 1020210091180-A/6227: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTT
>OF310631.1 KR 1020210091180-A/6214: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTC
>OF310618.1 KR 1020210091180-A/6201: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCT
>OF310606.1 KR 1020210091180-A/6189: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTG
>OF310594.1 KR 1020210091180-A/6177: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGT
>OF310582.1 KR 1020210091180-A/6165: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTC
>OF310569.1 KR 1020210091180-A/6152: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCC
>OF310556.1 KR 1020210091180-A/6139: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCA
>OF310543.1 KR 1020210091180-A/6126: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGC
>OF310533.1 KR 1020210091180-A/6116: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAG
>OF310521.1 KR 1020210091180-A/6104: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAA
>OF310505.1 KR 1020210091180-A/6088: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAG
>OF310391.1 KR 1020210091180-A/5974: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATT
>OF310383.1 KR 1020210091180-A/5966: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCAT
>OF310375.1 KR 1020210091180-A/5958: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCA
>OF310368.1 KR 1020210091180-A/5951: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGC
>OF310340.1 KR 1020210091180-A/5923: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGAT
>OF310327.1 KR 1020210091180-A/5910: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGA
>OF310280.1 KR 1020210091180-A/5863: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGT
>OF310268.1 KR 1020210091180-A/5851: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTT
>OF310255.1 KR 1020210091180-A/5838: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTC
>OF310243.1 KR 1020210091180-A/5826: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCT
>OF310231.1 KR 1020210091180-A/5814: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTG
>OF310219.1 KR 1020210091180-A/5802: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGT
>OF310207.1 KR 1020210091180-A/5790: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTC
>OF310194.1 KR 1020210091180-A/5777: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCC
>OF310181.1 KR 1020210091180-A/5764: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCA
>OF310168.1 KR 1020210091180-A/5751: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGC
>OF310158.1 KR 1020210091180-A/5741: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAG
>OF310016.1 KR 1020210091180-A/5599: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATT
>OF310008.1 KR 1020210091180-A/5591: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCAT
>OF310000.1 KR 1020210091180-A/5583: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCA
>OF309993.1 KR 1020210091180-A/5576: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGC
>OF309965.1 KR 1020210091180-A/5548: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGAT
>OF309952.1 KR 1020210091180-A/5535: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGA
>OF310146.1 KR 1020210091180-A/5729: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAA
>OF310130.1 KR 1020210091180-A/5713: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAG
>OF309905.1 KR 1020210091180-A/5488: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGT
>OF309893.1 KR 1020210091180-A/5476: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTT
>OF309880.1 KR 1020210091180-A/5463: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTC
>OF309868.1 KR 1020210091180-A/5451: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCT
>OF309856.1 KR 1020210091180-A/5439: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTG
>OF309844.1 KR 1020210091180-A/5427: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGT
>OF309832.1 KR 1020210091180-A/5415: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTC
>OF309819.1 KR 1020210091180-A/5402: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCC
>OF309806.1 KR 1020210091180-A/5389: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCA
>OF309793.1 KR 1020210091180-A/5376: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGC
>OF309783.1 KR 1020210091180-A/5366: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAG
>OF309771.1 KR 1020210091180-A/5354: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAA
>OF309755.1 KR 1020210091180-A/5338: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAG
>OF309641.1 KR 1020210091180-A/5224: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATT
>OF309633.1 KR 1020210091180-A/5216: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCAT
>OF309625.1 KR 1020210091180-A/5208: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCA
>OF309618.1 KR 1020210091180-A/5201: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGC
>OF309518.1 KR 1020210091180-A/5101: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTT
>OF309590.1 KR 1020210091180-A/5173: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGAT
>OF309505.1 KR 1020210091180-A/5088: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTC
>OF309577.1 KR 1020210091180-A/5160: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGA
>OF309493.1 KR 1020210091180-A/5076: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCT
>OF309481.1 KR 1020210091180-A/5064: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTG
>OF309469.1 KR 1020210091180-A/5052: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGT
>OF309457.1 KR 1020210091180-A/5040: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTC
>OF309530.1 KR 1020210091180-A/5113: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGT
>OF309444.1 KR 1020210091180-A/5027: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCC
>OF309431.1 KR 1020210091180-A/5014: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCA
>OF309418.1 KR 1020210091180-A/5001: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGC
>OF309408.1 KR 1020210091180-A/4991: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAG
>OF309396.1 KR 1020210091180-A/4979: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAA
>OF309380.1 KR 1020210091180-A/4963: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAG
>OF309266.1 KR 1020210091180-A/4849: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATT
>OF309258.1 KR 1020210091180-A/4841: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCAT
>OF309250.1 KR 1020210091180-A/4833: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCA
>OF309243.1 KR 1020210091180-A/4826: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGC
>OF309215.1 KR 1020210091180-A/4798: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGAT
>OF309202.1 KR 1020210091180-A/4785: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGA
>OF309155.1 KR 1020210091180-A/4738: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGT
>OF309118.1 KR 1020210091180-A/4701: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCT
>OF309106.1 KR 1020210091180-A/4689: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTG
>OF309094.1 KR 1020210091180-A/4677: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGT
>OF309082.1 KR 1020210091180-A/4665: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTC
>OF309069.1 KR 1020210091180-A/4652: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCC
>OF309056.1 KR 1020210091180-A/4639: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCA
>OF309043.1 KR 1020210091180-A/4626: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGC
>OF309033.1 KR 1020210091180-A/4616: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAG
>OF309021.1 KR 1020210091180-A/4604: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAA
>OF309005.1 KR 1020210091180-A/4588: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAG
>OF309143.1 KR 1020210091180-A/4726: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTT
>OF309130.1 KR 1020210091180-A/4713: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTC
>OF308891.1 KR 1020210091180-A/4474: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATT
>OF308883.1 KR 1020210091180-A/4466: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCAT
>OF308875.1 KR 1020210091180-A/4458: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCA
>OF308868.1 KR 1020210091180-A/4451: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGC
>OF308840.1 KR 1020210091180-A/4423: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGAT
>OF308827.1 KR 1020210091180-A/4410: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGA
>OF349057.1 KR 1020210126155-A/99: CHEMICAL COMPOSITIONS AND METHODS OF USING SAME
TTCACTGTAG
>OF349055.1 KR 1020210126155-A/97: CHEMICAL COMPOSITIONS AND METHODS OF USING SAME
AGCTTCTTAT
>OF308780.1 KR 1020210091180-A/4363: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGT
>OF308768.1 KR 1020210091180-A/4351: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTT
>OF308755.1 KR 1020210091180-A/4338: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTC
>OF308743.1 KR 1020210091180-A/4326: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCT
>OF308731.1 KR 1020210091180-A/4314: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTG
>OF348960.1 KR 1020210126155-A/2: CHEMICAL COMPOSITIONS AND METHODS OF USING SAME
AACACCACCT
>OF308719.1 KR 1020210091180-A/4302: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGT
>OF308707.1 KR 1020210091180-A/4290: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTC
>OF308694.1 KR 1020210091180-A/4277: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCC
>OF308681.1 KR 1020210091180-A/4264: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCA
>OF308668.1 KR 1020210091180-A/4251: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGC
>OF308658.1 KR 1020210091180-A/4241: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAG
>OF308646.1 KR 1020210091180-A/4229: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAA
>OF308630.1 KR 1020210091180-A/4213: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAG
>OF308516.1 KR 1020210091180-A/4099: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATT
>OF308508.1 KR 1020210091180-A/4091: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCAT
>OF308500.1 KR 1020210091180-A/4083: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCA
>OF308493.1 KR 1020210091180-A/4076: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGC
>OF308465.1 KR 1020210091180-A/4048: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGAT
>OF308452.1 KR 1020210091180-A/4035: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGA
>OF308405.1 KR 1020210091180-A/3988: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGT
>OF308393.1 KR 1020210091180-A/3976: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTT
>OF308380.1 KR 1020210091180-A/3963: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTC
>OF308368.1 KR 1020210091180-A/3951: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCT
>OF308356.1 KR 1020210091180-A/3939: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTG
>OF308344.1 KR 1020210091180-A/3927: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGT
>OF308332.1 KR 1020210091180-A/3915: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTC
>OF308319.1 KR 1020210091180-A/3902: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCC
>OF308306.1 KR 1020210091180-A/3889: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCA
>OF308293.1 KR 1020210091180-A/3876: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGC
>OF308283.1 KR 1020210091180-A/3866: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAG
>OF308271.1 KR 1020210091180-A/3854: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAA
>OF308255.1 KR 1020210091180-A/3838: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAG
>OF308141.1 KR 1020210091180-A/3724: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATT
>OF307934.1 KR 1020210091180-A/3517: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCC
>OF307921.1 KR 1020210091180-A/3504: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCA
>OF307908.1 KR 1020210091180-A/3491: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGC
>OF307898.1 KR 1020210091180-A/3481: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAG
>OF307886.1 KR 1020210091180-A/3469: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAA
>OF307870.1 KR 1020210091180-A/3453: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAG
>OF308133.1 KR 1020210091180-A/3716: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCAT
>OF308124.1 KR 1020210091180-A/3707: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCA
>OF308116.1 KR 1020210091180-A/3699: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGC
>OF308105.1 KR 1020210091180-A/3688: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGG
>OF308094.1 KR 1020210091180-A/3677: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATG
>OF308081.1 KR 1020210091180-A/3664: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGAT
>OF308068.1 KR 1020210091180-A/3651: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGA
>OF307756.1 KR 1020210091180-A/3339: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATT
>OF307748.1 KR 1020210091180-A/3331: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCAT
>OF307739.1 KR 1020210091180-A/3322: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCA
>OF308021.1 KR 1020210091180-A/3604: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGT
>OF308009.1 KR 1020210091180-A/3592: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTT
>OF307996.1 KR 1020210091180-A/3579: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTC
>OF307983.1 KR 1020210091180-A/3566: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCT
>OF307971.1 KR 1020210091180-A/3554: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTG
>OF307959.1 KR 1020210091180-A/3542: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGT
>OF307947.1 KR 1020210091180-A/3530: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTC
>OF307731.1 KR 1020210091180-A/3314: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGC
>OF307720.1 KR 1020210091180-A/3303: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGG
>OF307709.1 KR 1020210091180-A/3292: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATG
>OF307696.1 KR 1020210091180-A/3279: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGAT
>OF307683.1 KR 1020210091180-A/3266: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGA
>OF307636.1 KR 1020210091180-A/3219: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGT
>OF307624.1 KR 1020210091180-A/3207: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTT
>OF307611.1 KR 1020210091180-A/3194: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTC
>OF307598.1 KR 1020210091180-A/3181: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCT
>OF307586.1 KR 1020210091180-A/3169: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTG
>OF307574.1 KR 1020210091180-A/3157: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGT
>OF307562.1 KR 1020210091180-A/3145: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTC
>OF307549.1 KR 1020210091180-A/3132: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCC
>OF307536.1 KR 1020210091180-A/3119: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCA
>OF307523.1 KR 1020210091180-A/3106: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGC
>OF307513.1 KR 1020210091180-A/3096: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAG
>OF307501.1 KR 1020210091180-A/3084: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAA
>OF307485.1 KR 1020210091180-A/3068: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAG
>OF307335.1 KR 1020210091180-A/2918: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGG
>OF307324.1 KR 1020210091180-A/2907: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATG
>OF307311.1 KR 1020210091180-A/2894: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGAT
>OF307298.1 KR 1020210091180-A/2881: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGA
>OF307371.1 KR 1020210091180-A/2954: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATT
>OF307363.1 KR 1020210091180-A/2946: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCAT
>OF307251.1 KR 1020210091180-A/2834: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGT
>OF307354.1 KR 1020210091180-A/2937: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCA
>OF307346.1 KR 1020210091180-A/2929: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGC
>OF307239.1 KR 1020210091180-A/2822: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTT
>OF307226.1 KR 1020210091180-A/2809: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTC
>OF307213.1 KR 1020210091180-A/2796: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCT
>OF307201.1 KR 1020210091180-A/2784: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTG
>OF307189.1 KR 1020210091180-A/2772: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGT
>OF307177.1 KR 1020210091180-A/2760: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTC
>OF307164.1 KR 1020210091180-A/2747: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCC
>OF307151.1 KR 1020210091180-A/2734: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCA
>OF307138.1 KR 1020210091180-A/2721: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGC
>OF307128.1 KR 1020210091180-A/2711: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAG
>OF307116.1 KR 1020210091180-A/2699: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAA
>OF307100.1 KR 1020210091180-A/2683: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAG
>OF306986.1 KR 1020210091180-A/2569: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATT
>OF306978.1 KR 1020210091180-A/2561: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCAT
>OF306969.1 KR 1020210091180-A/2552: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCA
>OF306961.1 KR 1020210091180-A/2544: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGC
>OF306950.1 KR 1020210091180-A/2533: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGG
>OF306939.1 KR 1020210091180-A/2522: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATG
>OF306926.1 KR 1020210091180-A/2509: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGAT
>OF306913.1 KR 1020210091180-A/2496: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGA
>OF306866.1 KR 1020210091180-A/2449: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGT
>OF306854.1 KR 1020210091180-A/2437: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTT
>OF306743.1 KR 1020210091180-A/2326: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAG
>OF306841.1 KR 1020210091180-A/2424: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTC
>OF306731.1 KR 1020210091180-A/2314: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAA
>OF306828.1 KR 1020210091180-A/2411: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCT
>OF306715.1 KR 1020210091180-A/2298: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAG
>OF306816.1 KR 1020210091180-A/2399: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTG
>OF306804.1 KR 1020210091180-A/2387: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGT
>OF306792.1 KR 1020210091180-A/2375: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTC
>OF306779.1 KR 1020210091180-A/2362: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCC
>OF306766.1 KR 1020210091180-A/2349: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCA
>OF306753.1 KR 1020210091180-A/2336: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGC
>OF306541.1 KR 1020210091180-A/2124: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGAT
>OF306528.1 KR 1020210091180-A/2111: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGA
>OF306481.1 KR 1020210091180-A/2064: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGT
>OF306469.1 KR 1020210091180-A/2052: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTT
>OF306456.1 KR 1020210091180-A/2039: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTC
>OF306443.1 KR 1020210091180-A/2026: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCT
>OF306431.1 KR 1020210091180-A/2014: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTG
>OF306419.1 KR 1020210091180-A/2002: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGT
>OF306407.1 KR 1020210091180-A/1990: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTC
>OF306394.1 KR 1020210091180-A/1977: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCC
>OF306601.1 KR 1020210091180-A/2184: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATT
>OF306593.1 KR 1020210091180-A/2176: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCAT
>OF306381.1 KR 1020210091180-A/1964: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCA
>OF306584.1 KR 1020210091180-A/2167: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCA
>OF306368.1 KR 1020210091180-A/1951: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGC
>OF306576.1 KR 1020210091180-A/2159: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGC
>OF306358.1 KR 1020210091180-A/1941: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAG
>OF306565.1 KR 1020210091180-A/2148: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGG
>OF306346.1 KR 1020210091180-A/1929: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAA
>OF306554.1 KR 1020210091180-A/2137: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATG
>OF306330.1 KR 1020210091180-A/1913: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAG
>OF306216.1 KR 1020210091180-A/1799: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATT
>OF306208.1 KR 1020210091180-A/1791: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCAT
>OF306199.1 KR 1020210091180-A/1782: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCA
>OF306191.1 KR 1020210091180-A/1774: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGC
>OF306180.1 KR 1020210091180-A/1763: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGG
>OF306169.1 KR 1020210091180-A/1752: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATG
>OF306156.1 KR 1020210091180-A/1739: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGAT
>OF306143.1 KR 1020210091180-A/1726: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGA
>OF306096.1 KR 1020210091180-A/1679: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGT
>OF306084.1 KR 1020210091180-A/1667: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTT
>OF306071.1 KR 1020210091180-A/1654: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTC
>OF306058.1 KR 1020210091180-A/1641: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCT
>OF306046.1 KR 1020210091180-A/1629: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTG
>OF306034.1 KR 1020210091180-A/1617: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGT
>OF306022.1 KR 1020210091180-A/1605: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTC
>OF306009.1 KR 1020210091180-A/1592: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCC
>OF305996.1 KR 1020210091180-A/1579: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCA
>OF305983.1 KR 1020210091180-A/1566: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGC
>OF305973.1 KR 1020210091180-A/1556: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAG
>OF305961.1 KR 1020210091180-A/1544: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAA
>OF305945.1 KR 1020210091180-A/1528: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAG
>OF305831.1 KR 1020210091180-A/1414: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATT
>OF305823.1 KR 1020210091180-A/1406: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCAT
>OF305815.1 KR 1020210091180-A/1398: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCA
>OF305808.1 KR 1020210091180-A/1391: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGC
>OF305782.1 KR 1020210091180-A/1365: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGAT
>OF305769.1 KR 1020210091180-A/1352: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGA
>OF305722.1 KR 1020210091180-A/1305: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGT
>OF305710.1 KR 1020210091180-A/1293: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTT
>OF305697.1 KR 1020210091180-A/1280: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTC
>OF305685.1 KR 1020210091180-A/1268: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCT
>OF305673.1 KR 1020210091180-A/1256: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTG
>OF305661.1 KR 1020210091180-A/1244: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGT
>OF305649.1 KR 1020210091180-A/1232: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTC
>OF305636.1 KR 1020210091180-A/1219: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCC
>OF305458.1 KR 1020210091180-A/1041: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATT
>OF305450.1 KR 1020210091180-A/1033: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCAT
>OF305441.1 KR 1020210091180-A/1024: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCA
>OF305433.1 KR 1020210091180-A/1016: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGC
>OF305422.1 KR 1020210091180-A/1005: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGG
>OF305412.1 KR 1020210091180-A/995: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATG
>OF305623.1 KR 1020210091180-A/1206: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCA
>OF305401.1 KR 1020210091180-A/984: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGAT
>OF305610.1 KR 1020210091180-A/1193: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGC
>OF305388.1 KR 1020210091180-A/971: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGA
>OF305600.1 KR 1020210091180-A/1183: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAG
>OF305588.1 KR 1020210091180-A/1171: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAA
>OF305572.1 KR 1020210091180-A/1155: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAG
>OF305341.1 KR 1020210091180-A/924: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGT
>OF305329.1 KR 1020210091180-A/912: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTT
>OF305316.1 KR 1020210091180-A/899: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTC
>OF305303.1 KR 1020210091180-A/886: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCT
>OF305291.1 KR 1020210091180-A/874: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTG
>OF305279.1 KR 1020210091180-A/862: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGT
>OF305267.1 KR 1020210091180-A/850: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTC
>OF305254.1 KR 1020210091180-A/837: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCC
>OF305241.1 KR 1020210091180-A/824: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCA
>OF305228.1 KR 1020210091180-A/811: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGC
>OF305218.1 KR 1020210091180-A/801: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAG
>OF305206.1 KR 1020210091180-A/789: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAA
>OF305190.1 KR 1020210091180-A/773: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAG
>OF304953.1 KR 1020210091180-A/536: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTT
>OF305076.1 KR 1020210091180-A/659: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATT
>OF305068.1 KR 1020210091180-A/651: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCAT
>OF305060.1 KR 1020210091180-A/643: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCA
>OF305053.1 KR 1020210091180-A/636: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGC
>OF305025.1 KR 1020210091180-A/608: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGAT
>OF305012.1 KR 1020210091180-A/595: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGA
>OF304940.1 KR 1020210091180-A/523: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTC
>OF304965.1 KR 1020210091180-A/548: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGT
>OF304928.1 KR 1020210091180-A/511: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCT
>OF304916.1 KR 1020210091180-A/499: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTG
>OF304904.1 KR 1020210091180-A/487: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGT
>OF304892.1 KR 1020210091180-A/475: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTC
>OF304879.1 KR 1020210091180-A/462: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCC
>OF304866.1 KR 1020210091180-A/449: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCA
>OF304853.1 KR 1020210091180-A/436: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGC
>OF304843.1 KR 1020210091180-A/426: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAG
>OF304831.1 KR 1020210091180-A/414: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAA
>OF304815.1 KR 1020210091180-A/398: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAG
>OF304701.1 KR 1020210091180-A/284: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATT
>OF304693.1 KR 1020210091180-A/276: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCAT
>OF304684.1 KR 1020210091180-A/267: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCA
>OF304676.1 KR 1020210091180-A/259: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGC
>OF304665.1 KR 1020210091180-A/248: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGG
>OF304654.1 KR 1020210091180-A/237: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATG
>OF304641.1 KR 1020210091180-A/224: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGAT
>OF304628.1 KR 1020210091180-A/211: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGA
>OF304581.1 KR 1020210091180-A/164: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGT
>OF304569.1 KR 1020210091180-A/152: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTT
>OF304556.1 KR 1020210091180-A/139: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTC
>OF304543.1 KR 1020210091180-A/126: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCT
>OF304531.1 KR 1020210091180-A/114: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTG
>OF304519.1 KR 1020210091180-A/102: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGT
>OF304507.1 KR 1020210091180-A/90: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTC
>OF304494.1 KR 1020210091180-A/77: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCC
>OF304481.1 KR 1020210091180-A/64: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCA
>OF304468.1 KR 1020210091180-A/51: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGC
>OF304458.1 KR 1020210091180-A/41: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAG
>OF304446.1 KR 1020210091180-A/29: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAA
>OF304423.1 KR 1020210082193-A/150: MINIATURIZED DYSTROPHINS AND USES THEREOF
GCCRCCATGG
>OF299741.1 KR 1020210131243-A/18: USE OF DOWNREGULATED MIRNA FOR DIAGNOSIS AND TREATMENT
CGTGTATGAC
>OF299728.1 KR 1020210131243-A/5: USE OF DOWNREGULATED MIRNA FOR DIAGNOSIS AND TREATMENT
CCGTGTATGA
>OF299697.1 KR 1020210131242-A/18: USE OF UPREGULATED MIRNA FOR DIAGNOSIS AND TREATMENT
CGTGTATGAC
>OF299684.1 KR 1020210131242-A/5: USE OF UPREGULATED MIRNA FOR DIAGNOSIS AND TREATMENT
CCGTGTATGA
>OF297827.1 KR 1020210133626-A/20: Medium composition for in vitro culture of Prunus africana and mass production method of Prunus africana using the same
TCTACGTCGG
>OF297826.1 KR 1020210133626-A/19: Medium composition for in vitro culture of Prunus africana and mass production method of Prunus africana using the same
AGATGCAGCC
>OF297825.1 KR 1020210133626-A/18: Medium composition for in vitro culture of Prunus africana and mass production method of Prunus africana using the same
CCACTGCGTC
>OF297824.1 KR 1020210133626-A/17: Medium composition for in vitro culture of Prunus africana and mass production method of Prunus africana using the same
GGTGACGCAG
>OF297823.1 KR 1020210133626-A/16: Medium composition for in vitro culture of Prunus africana and mass production method of Prunus africana using the same
CTTTGCCCAC
>OF297822.1 KR 1020210133626-A/15: Medium composition for in vitro culture of Prunus africana and mass production method of Prunus africana using the same
GAAACGGGTG
>OF297821.1 KR 1020210133626-A/14: Medium composition for in vitro culture of Prunus africana and mass production method of Prunus africana using the same
CCGCCAACAG
>OF297820.1 KR 1020210133626-A/13: Medium composition for in vitro culture of Prunus africana and mass production method of Prunus africana using the same
GGCGGTTGTC
>OF297819.1 KR 1020210133626-A/12: Medium composition for in vitro culture of Prunus africana and mass production method of Prunus africana using the same
GGCGGGTTTG
>OF297818.1 KR 1020210133626-A/11: Medium composition for in vitro culture of Prunus africana and mass production method of Prunus africana using the same
CCGCCCAAAC
>OF298873.1 KR 1020210116216-A/8: SELECTIVE MODIFYING METHOD OF NUCLEOTIDE
ATTCACTCAG
>OF297814.1 KR 1020210133626-A/7: Medium composition for in vitro culture of Prunus africana and mass production method of Prunus africana using the same
CCGCCTAGTC
>OF297813.1 KR 1020210133626-A/6: Medium composition for in vitro culture of Prunus africana and mass production method of Prunus africana using the same
CCACTAGTCC
>OF297812.1 KR 1020210133626-A/5: Medium composition for in vitro culture of Prunus africana and mass production method of Prunus africana using the same
GGTGATCAGG
>OF297811.1 KR 1020210133626-A/4: Medium composition for in vitro culture of Prunus africana and mass production method of Prunus africana using the same
CACTGTACGG
>OF297810.1 KR 1020210133626-A/3: Medium composition for in vitro culture of Prunus africana and mass production method of Prunus africana using the same
GTGACATGCC
>OF297809.1 KR 1020210133626-A/2: Medium composition for in vitro culture of Prunus africana and mass production method of Prunus africana using the same
GGCGTAGATG
>OF297808.1 KR 1020210133626-A/1: Medium composition for in vitro culture of Prunus africana and mass production method of Prunus africana using the same
CCGCATCTAC
>OF297667.1 KR 1020210124566-A/3: KIT FOR ANALYZING PHTHALIC BASED MATERIAL USING APTAMER AND METHOD FOR ANALYZING PHTHALIC BASED MATERIAL USING THE SAME
GGGGGGGGGG
>pdb|7RBG|P Chain P, Human DNA polymerase beta crosslinked ternary complex 1
GCTGATGCGC
>pdb|7RBF|P Chain P, Human DNA polymerase beta crosslinked binary complex - B
GCTGATGCGC
>pdb|7VM9|A Chain A, Solution NMR structures of DNA minidumbbell formed with two regular CTTTG pentaloops
CTTTGCTTTG
>pdb|6VA3|B Chain B, Solution Structure of the Tau pre-mRNA Exon 10 Splicing Regulatory Element Bound to MQC
CACACGTCGG
>pdb|6CIM|I Chain I, Pre-Reaction Complex, RAG1(E962Q)/2-nicked/intact 12/23RSS complex in Mn2+
GCCTGTCTTA
>pdb|5VS1|P Chain P, Human DNA polymerase beta pre-catalytic 8-oxoG:dA extension complex with dTTP bound in non-planar conformation
CTGATGCGCA
>pdb|2KP4|B Chain B, Structure of 2'F-ANA/RNA hybrid duplex
CCATTATAGC
>pdb|2KP3|B Chain B, Structure of ANA-RNA hybrid duplex
CCATTATAGC
>pdb|219D|A Chain A, DNA/RNA HYBRID DUPLEX (5'-D(*GP*CP*TP*AP*TP*AP*APS*TP*GP*G)-3')(DOT) (5'-R(*CP*CP*AP*UP*UP*AP*UP*AP*GP*C)-3') WITH A PHOSPHOROTHIOATE MOIETY
GCTATAANGG
>pdb|2DD3|A Chain A, An alternating sheared AA pair in 5'GGUGAAGGCU/3'PCCGAAGCCG: II. The minor conformation with A6/A5/A16 stack
GGTGAAGGCT
>pdb|2DD3|B Chain B, An alternating sheared AA pair in 5'GGUGAAGGCU/3'PCCGAAGCCG: II. The minor conformation with A6/A5/A16 stack
GCCGAAGCCN
>pdb|219D|B Chain B, DNA/RNA HYBRID DUPLEX (5'-D(*GP*CP*TP*AP*TP*AP*APS*TP*GP*G)-3')(DOT) (5'-R(*CP*CP*AP*UP*UP*AP*UP*AP*GP*C)-3') WITH A PHOSPHOROTHIOATE MOIETY
CCATTATAGC
>pdb|2ICZ|B Chain B, NMR Structures of the Expanded DNA 10bp xTGxTAxCxGCxAxGT:xACTxGCGxTAxCA
NCTNCGNANA
>pdb|7D3X|B Chain B, Non-specific and specific interactions work cooperatively to promote cytidine deamination catalyzed by APOBEC3A
ATTTTCAATT
>pdb|6VA4|B Chain B, Solution Structure of the Tau pre-mRNA Exon 10 Splicing Regulatory Element Bound to MIP
CACACGTCGG
>pdb|5WO0|P Chain P, DNA polymerase beta substrate complex with incoming 5-FodUTP
GCTGATGCGC
>pdb|5K83|H Chain H, Crystal Structure of a Primate APOBEC3G N-Domain, in Complex with ssDNA
TTTTTTTTTT
>pdb|5K83|J Chain J, Crystal Structure of a Primate APOBEC3G N-Domain, in Complex with ssDNA
TTTTTTTTTT
>pdb|5K83|I Chain I, Crystal Structure of a Primate APOBEC3G N-Domain, in Complex with ssDNA
TTTTTTTTTT
>pdb|7RBH|P Chain P, Human DNA polymerase beta crosslinked ternary complex 2
GCTGATGCGC
>pdb|7RBE|P Chain P, Human DNA polymerase beta crosslinked binary complex - A
GCTGATGCGC
>pdb|7D3W|B Chain B, Non-specific and specific interactions work cooperatively to promote cytidine deamination catalyzed by APOBEC3A
ATTTTCAATT
>pdb|6SGC|i1 Chain i1, Rabbit 80S ribosome stalled on a poly(A) tail
NAAAAAAAAA
>pdb|5VS2|P Chain P, Human DNA polymerase beta pre-catalytic 8-oxoG:dA extension complex with dTTP bound in Watson-Crick conformation
CTGATGCGCA
>pdb|5VRX|P Chain P, Human DNA polymerase beta pre-catalytic 8-oxoG:dC extension complex with dTTP bound in Watson-Crick conformation
CTGATGCGCC
>pdb|5VRW|P Chain P, Human DNA polymerase beta pre-catalytic 8-oxoG:dC extension complex with dTTP bound in non-planar conformation
CTGATGCGCC
>pdb|2DD2|A Chain A, An alternating sheared AA pair in 5'GGUGAAGGCU/3'PCCGAAGCCG: I. The major conformation with A6/A15/A16 stack
GGTGAAGGCT
>pdb|2DD1|A Chain A, Three consecutive sheared GA pairs in 5'GGUGGAGGCU/3'PCCAAAGCCG
GGTGGAGGCT
>pdb|2DD2|B Chain B, An alternating sheared AA pair in 5'GGUGAAGGCU/3'PCCGAAGCCG: I. The major conformation with A6/A15/A16 stack
GCCGAAGCCN
>pdb|2DD1|B Chain B, Three consecutive sheared GA pairs in 5'GGUGGAGGCU/3'PCCAAAGCCG
GCCGAAACCN
>pdb|226D|B Chain B, SOLUTION CONFORMATION OF A BIZELESIN A-TRACT DUPLEX ADDUCT, NMR, 1 STRUCTURE
CGTAAAAACG
>pdb|226D|A Chain A, SOLUTION CONFORMATION OF A BIZELESIN A-TRACT DUPLEX ADDUCT, NMR, 1 STRUCTURE
CGTTTTTACG
>MY787236.1 Sequence 17 from patent US 11208691
CATGCTAGTA
>MY787235.1 Sequence 16 from patent US 11208691
CATGCTAGTA
>MY787234.1 Sequence 15 from patent US 11208691
CATGCGAGAT
>MY787233.1 Sequence 14 from patent US 11208691
CATGCTAGTA
>MY787232.1 Sequence 13 from patent US 11208691
CATGCTAGTA
>MY787230.1 Sequence 11 from patent US 11208691
CATGCGAGAT
